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Di-(2-ethylhexyl) phthalate (DEHP) is a ubiquitous environmental 
toxicant. The active metabolite of DEHP, mono-(2-ethylhexyl) phthalate 
(MEHP), is ultimately responsible for disrupting the process of spermatogenesis 
and promoting germ cell death. In addition, this toxicant has been positively 
correlated with developmental problems such as cryptorchidism, a derangement 
of the seminiferous tubules, and a syndrome called testicular dysgenesis, leading 
to reduced sperm number. The potential impact of MEHP on human fertility 
justifies a detailed investigation into the mechanisms by which this agent causes 
germ cell death. MEHP is known to directly target and damage the Sertoli cell, a 
testicular cell whose main function is to  support  the development of the principle 
germ cell types from the earliest stem cell to the most mature spermatozoa. This 
dissertation examines the downstream effect of Sertoli cell damage on germ cell 







undergo apoptotic elimination. Specifically, the stabilization of the p53 protein is 
proposed to be an important upstream determinant of Fas-mediated apoptosis in 
germ cells following MEHP exposure. Furthermore, that the resulting cell death is 
the result of increased death receptor expression and c-FLIPL ubiquitinylation. 
The mechanism is speculated to reside in the spermatocyte sub-population of 
germ cells, which appears to be most responsive to changes in apoptosis.  
Exposures of wild type mice to MEHP caused an increased p53 stability 
and elevated protein levels of the membrane-bound death receptors Fas and DR5 
in testicular spermatocytes. The expression of these proteins occur coincident 
with increases in spermatocyte apoptosis and are driven by p53 activity. To 
further assess the mechanisms responsible for the sensitivity of germ cells to 
undergo p53-mediated apoptosis, we used the germ cell line GC-2spd(ts) (a p53 
temperature sensitive spermatocyte-like cell line that allows for p53 nuclear 
localization at 32°C but not 37°C). Induction of the p53 protein led to higher 
levels of the death receptors DR5 and Fas, activation of caspase-8, and decreases 
in c-FLIPL. Addition of TRAIL (the cognate ligand for DR5) and the agonistic 
DR5 agonistic antibody MD5-1, triggered a robust synergistic increase of 
apoptosis in GC-2 cells maintained at the p53 permissive temperature (32°C). 
DR5 levels on the germ cell plasma membrane were considerably enhanced 
following these treatments. Immunoprecipitation of c-FLIPL suggests that the 
protein is ubiquitinylated after cellular stress and concomitant with p53 activity. 
Experiments also reveal that c-FLIPL levels may be influenced by Itch, a 
regulatory protein able to label targets for the proteasomal degradation using a 
ubiquitinylating E3 ligase. Immunohistochemical detection in adult wild type 
mouse testis show robust increases in Itch protein levels upon MEHP treatment 
(1g/kg) and subsequently localization to the cytoplasm of meiotic spermatocyte 
germ cells. Western blot analysis of testis from MEHP treated mice also show a 
correlation between the reduction of c-FLIPL and an increase in Itch threonine-
222 phosphorylation, a necessary modification for its E3 ligase function. These 







promotes germ cell death through the extrinsic pathway, ultimately leading to 
disruption of spermatogenesis and testicular dysgenesis in mammals. However, 
removal of Itch also show increases in apoptosis and Itch protein deficient mice 
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Chapter 1:  
Introduction 
 
1.1 The Testis and Spermatogenesis 
 
A. Basic Testis Physiology 
 
Spermatogenesis is the process of producing mature, haploid spermatozoa 
for fertilization of the female egg. The sites of gamete production are the testes; 
round, capsule-like paired organs located externally in most mammals. 
Exceptions include whales and some land mammals, such as elephants, which 
internalize the testis to maintain the optimal temperature for robust fertility 
(Gaeth, 1999). Attached to the testis is the epididymis, a tube that stores 
spermatozoa upon external delivery via ejaculation. 
An individual testis is divided into two regions: the interstitial 
compartment, which contains blood and interstitial fluid, and the seminiferous 
tubules, which contain testicular cells organized in a defined architecture (Fig. 
1.1). The testicular interstitial compartment contains primarily Leydig cells, 
which reside in the spaces between individual seminiferous tubules. This Leydig 
cell is the testicular site of steroid synthesis and is the principle supplier of 
testosterone in the testis (Zirkin, 2000). The interstitial space also contains a high 
number of macrophages, a phagocyte important in cell immunity. Macrophages 
may also aid in the regulation of testosterone levels by releasing reactive oxygen 
species (ROS) to prevent overexpression of the steroid (Hales, 2002). 
Spermatogenesis occurs specifically in the seminiferous tubules of the 
testis. They are composed of lengthy stretches of tissue that emanate from an 
external duct (the Rete testis) and are filled with germ cells and Sertoli cells. The 
tubules form long loops that give the testis their distinct ovular shape. Peritubular 
myoid cells line the outside of the seminiferous tubules and act to secrete 
components of extracellular matrix, such as actin filaments, and acts to provide 
structural integrity and physical support (Tung, 1990). Within the seminiferous 
tubule compartment is an epithelium that contains two cell types: Sertoli cells and 
 2 
germ cells. Sertoli cells are of one type, whereas germ cells are divided into four 
major classes, in the order of least to greatest maturity: spermatogonia, 
spermatocytes, spermatids, and spermatozoa.  
Each testis contains hundreds of closely associated tubules. Each complete 
individual tubule contains germ cells of all possible maturities (called “stages”) 
and associated Sertoli cells. A cross section of a seminiferous tubule reveals a ring 
of cells organized in a defined manner according to developmental age, or stage 
(Fig. 1.1 & 1.2). There are twelve stages in the rodent spermatogenic process and 
each stage marks a place in the development and maturation of germ cells. The 
least mature cells reside along the outermost basal membrane, while the most 
mature moves towards the lumen, at the center of the tubule. The proper 
organization of germ cell types in concert with the Sertoli cell is fundamental to 
testis physiology and consequently spermatogenesis.  
The Sertoli cell is of interest as it acts as the “nurse” to germ cells, 
providing nutrients, growth factors, and other components vital to their sustained 
health. The Sertoli cell is able to mitigate this exchange of materials due to its 
ability to physically contact and interact with up to 30 germ cells at once 
(Skinner, 2005). Indeed, the cytoplasm of the Sertoli cell is distributed through 
the layers of adjacent germ cells, stretching from the basement membrane to 
nearly the lumen. The enveloping character of the Sertoli cell cytoplasm accounts 
for its wide range of functions. For example, Sertoli cells can phagocytize 
damaged germ cell material called residual bodies and actively clear other 
unneeded components from the tubule. However, the Sertoli cell fills numerous 
other roles, particularly in providing physical support to the germ cell as well as 
paracrine signaling such as growth factor production. 
Sertoli cells produce a tight junction with each other, forming what is 
sometimes described as the “Sertoli cell barrier” or “blood testis barrier.” (Weber, 
1988) The tight junctions form two distinct compartments within the seminiferous 
epithelium, one below the junction (basal) and one above (adluminal) (Fig. 1.3). 
The distinction between the two regions is important because the cells of the basal 
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compartment have direct access to constituents diffused from the blood and 
lymphatic fluids. Early germ cell types, including spermatogonia and the least 
mature spermatocytes, are located in the basal compartment (Russell, 1977). 
Above the tight junction, in the adluminal compartment, resides the majority of 
the spermatocytes and all other mature germ cells.  
The cells that occupy the region above the tight junction rely, in most 
cases, completely upon what is secreted by the Sertoli cell for survival. One 
example is lactate, the principle energy substrate for germ cells, which is 
delivered exclusively by the Sertoli cell (Jutte, 1982). Additionally, the Sertoli 
cells control the levels of hormones, such as leutenizing hormone (LH) and 
follicle stimulating hormone (FSH), both important in controlling differentiation 
and proliferation of germ cells (Russell, 1990). Sertoli cells regulate FSH 
balances using activin or its antagonist, inhibin (Meehan, 2000). Increasing FSH 
leads to augmented levels of androgen-binding protein, testosterone, and 17-β 
estradiol, inducing spermatogenesis. On the other hand, increased inhibin 
secretion will prevent this process. Therefore,  regulating  hormone availability to 
the germ cell is an example of the paracrine relationship that the two cells feature. 
Sertoli germs also secrete various factors directly to the germ cells, including anti-
Mullerian hormone required for fetal testis development (Boukari, 2007). 
Paracrine hormone signaling and nutrient provision is critical to cells 
located in the adluminal department. However, it is important to emphasize that 
cells residing within both compartments are reliant on the structural support 
conferred by the Sertoli cell. The Sertoli cell acts as a scaffold that maintains 
germ cells in the proper place and orientation for their development throughout 
spermatogenesis. Elements of the Sertoli cell cytoskeleton are essential for 
positioning elongate spermatids for spermiation (sperm release) and intermediate 
filaments called vimentin probably act to orient Sertoli cells with Spermatocytes 
(Skinner, 2005),(Richburg, 1996). Loss of the proper architecture between the 
Sertoli cell and germ cell include failure to properly complete spermatogenesis 



























Fig. 1.1 Cross section of the testis. The testis is composed primarily of the 
seminiferous tubules, which contain germ cells and Sertoli cells and is the site of 
spermatogenesis. The interstitial space exists between the tubules and its main 
constituents are  Leydig cells and macrophages. The lumen is where spermiation 
occurs and spermatids are released to the epididymis. 



























Fig. 1.2 Germ cell types/stages. During spermatogenesis, each germ cell either 
undergoes mitosis or meiosis depending on its maturity. The spermatocyte is the 
only subtype to undergo meiosis. Round spermatids are recognized by a small 
acrosome located on end of the cell. Round spermatids elongate and are released 
from the lumen. 
Spermatogonia 
1 º Spermatocytes 









































Fig. 1.3 Germ cell organization. Sertoli cells divide the germ cell into two 
regions: the basal compartment below the tight junctions and the adluminal 
compartment above the tight junction. Sertoli cell signaling is particular important 


























B. Germ Cells and Spermatogenesis 
 
 Spermatogenesis is marked by the transformation of the germ cell from 
the early spermatogonia to the fully mature elongate spermatids (spermatozoa are 
defined after further maturation in the epididymis). The development of mature 
sperm is a stepwise process that progresses from the basement membrane of the 
seminiferous tubule to the lumen, where spermiation, or sperm release, occurs. 
The entire cycle requires precise timing and organization to proceed from the 
earliest stem-germ cells to the eventual release of spermatozoa. Small defects in 
timing, cell spacing, or hormone secretion can all result in lower sperm counts, 
and ultimately result in male infertility. Because cells can become damaged or 
apoptotic during spermatogenesis, not all germ cells become mature sperm. A 
pruning of these cells occur under normal physiological conditions, routinely 
eliminating 75% of the theoretically predicted total germ cell population (Allan, 
1972). Even so, healthy mammals typically generate approximately 100 million 
spermatozoa per day (Aitken, 2006). 
   The spermatogenic process is initiated with stem spermatagonia that are 
perpetually maintained at low levels. These most fundamental germ cell types 
proliferate rarely and give rise to slightly larger type A spermatogonia capable of 
pairing with each other. Eventually enough paired type A spermatogonia (AP) are 
able to align in the tubule, forming long strings of germ cells connected by 
structures known as intercellular bridges (Weber, 1987). The bridge conformation 
of consecutive AP spermatogonia are thought to promote clonality and 
subsequently divide by mitosis, resulting in the A1 cell (Huckins, 1978). A series 
of type A spermatogonia slightly more mature than the previous (designated A2-
A4 and A intermediate) is produced by cell division before forming the more 
numerous (and morphologically distinct) type B spermatogonia. All 
spermatagonia reside along the basement membrane, in the basal compartment, 
and are considered part of the proliferative phase of spermatogenesis. 
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 The next major germ cell group is the spermatocyte, which represents the 
meiotic phase of spermatogenesis. It is during this series of events that the genetic 
content of the gametes are halved, forming haploid cells with 23 chromosomes. 
Cross-over and genetic recombination also occurs during this developmental 
stage. The earliest spermatocyte cell types are the preleptotene (“resting”) 
spermatocytes and are the direct product of dividing type B spermatogonia. The 
preleptotene cell is found in the basal compartment along the basement 
membrane. However, the later stages of spermatocyte development show 
movement of the cells in the direction of the lumen, at the center of the tubule. 
Spermatocytes are able to undergo the first stages of meiosis when they have 
migrated as far as the adluminal compartment (Skinner, 2005).  
The process of meiosis is spread over four temporally controlled periods, 
in which chromosomes are formed (leptotene), aligned in sister chromatids 
(zygotene), allowed to undergo recombination via cross-over (pachytene), and 
when the chromosomes separate (diplotein). The pachytene period is the longest, 
lasting from one to two weeks in most  mammals. After meiosis II (in which the 
genetic material is halved again), the final product is a haploid round spermatid. 
Leading up to this stage, the germ cells have become progressively larger and 
rounder in shape. Generally, late stage spermatocytes and round spermatids are 
among the easiest cells to distinguish morphologically (Russell, 1990). 
 Round spermatids are gradually extended in shape and project a more 
pronounced acrosome, which is a specialized compartment emanating from the 
endoplasmic reticulum filled with lytic enzymes used to breech the egg membrane 
during fertilization (Austin, 1975). The acrosome is present throughout 
spermatogenesis but is most easily discernible in spermatids that have undergone 
an elongation in shape. Elongate spermatids develop into spermatzoa, a mature 
sperm that possesses a flagellum and motility. At the end of the process, 
spermatozoa are released from the testis via the Rete gland and enter the 
epididymis for further maturation and storage. 
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Spermatogenesis is sensitive to small imbalances in endocrine factors and 
stressors that promote such imbalances. Studies have show that there are actually 
three quarters less sperm produced than would be theoretically predicted based on 
division kinetics of the earlier germ cells (Allan, 1992). Much of this difference 
between the predicted numbers of germ cells and the actual numbers of mature 
spermatids produced can be attributed to apoptosis of germ cells. A naturally 
occurring increase in germ cell apoptosis can be seen during specific 
developmental periods such as during the “first wave” of spermatogenesis that 
arises during the pre-pubertal period (Rodriguez, 1997). This physiological cell 
death helps to denote the upper limit of germ cells that Sertoli cells can support 
and maintains the integrity of spermatogenic processes. Consequently, the number 
of healthy Sertoli cells will determine the level of germ cell death. Thus, 
apoptosis is a normal component of spermatogenesis. However, stress induced by 
toxicants such as MEHP can inappropriately trigger the apoptotic process, leading 
to reductions in normal levels of gametes and a loss of fertility. The use of MEHP 
will be discussed as part of the testicular injury model closing this chapter. 





A. General Description and Features 
 
Apoptosis is the process in which cells experience intentional or 
“programmed” death.  The term was first coined by Austrailian researcher John 
Kerr when he investigated controlled cell deletion as a means of physiological 
population control (Kerr, 1972). The origin of the term “programmed cell death” 
actually dates to 1965, when Lockshin and Williams described the apparently 
designed cell death that occurs during development of tadpole embryos 
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(Lockshin, 1965). The Greek word apoptosis literally translates to “falling off,” or 
“leaves falling off trees,” a metaphor that living matter sometimes dies to 
accommodate future health.  
 Apoptosis represents an orderly and efficient dismantling of cells that 
have been designated for termination. Accidental cell death is referred to as 
necrosis. Necrosis is a process by which the cell membrane is compromised, 
leading to a loss of osmotic control and an increased internal pressure within the 
cell. This pressure will usually culminate in a rupturing of the membrane that 
disrupts adjacent healthy cells (Krysko, 2006). The lysis of necrotic cells releases 
DNAses and lytic enzymes that result in inflammation and an immune response 
that clears necrotic cells and their affected neighbors (Jacotot, 2000). Unlike 
necrosis, in which injured cells spill their contents in an unorganized manner, 
apoptosis systematically breaks down the components of a cell and recycles the 
material.  
Kerr et al described the basic morphological features of apoptosis: cell 
shrinkage and loss of contact with adjacent cells, nuclear and cytoplasmic 
condensation, a budding process by which parts of the cell are wrapped in vesicles 
known as apoptotic bodies, and eventual phagocytosis via the activity of 
macrophages (Kerr, 1972). Early biochemical markers involve cleavage of CAD 
(caspase-activated DNase) from its inhibitor, ICAD (Inhibitor of caspase-
activated DNase) (Enari, 1998), (Kanouchi, 2005). Released CAD has a nuclear 
import sequence and is able to identify and cut DNA sequences within the nucleus 
(Fischer, 2003) (Nagata, 2000). The caspases (cysteine-aspartic acid proteases) 
responsible for ICAD processing are activated following an apoptotic stimulus 
and cleave a variety of substrates, including DNA repair proteins (notably PARP 
– poly ADP-ribose polymersase), cytoskeleton molecules such as actin and 
vimentin, and the nuclear support protein laminin (Hengartner, 2000). The latter 
structural protein is of particular importance, as its cleavage promotes the budding 
of the nuclear contents (Lazebnik, 1993).  
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One further characteristic of an actively apoptotic cell is the movement of 
phospholipid component phosphotidylserine from the inside of the plasma 
membrane to the outside. This lipid “flip-flop” transition occurs prior to the influx 
of phagocytizing macrophages and does in fact act as a signal to actively recruit 
those cells (Fadok, 1992). The process is useful for the indication of early 
apoptosis versus necrosis and can be detected in a straightforward cell death assay 
using flow cytometry. 
The first understanding of apoptosis genetics dates to the studies 
conducted by H. Robert Horvitz’s research group a decade after Kerr’s 
description of apoptotic characteristics. Horvitz used the model system C. 
elegans, a hermaphroditic nematode that exhibited an unusual but consistent 
pattern of death among its somatic cells: exactly 131 of 1090 cells die in the 
worm during development (Ellis, 1986).  Over the course of the next decade the 
cell death abnormal (ced) genes responsible for this phenomena would be 
identified and their proteins characterized. Inhibitors of cell death would be 
identified as well. For example, two of the earliest c. elgans apoptotic genes to be 
described was the pro-apoptotic ced-3 and the anti-apoptotic ced-9. These 
proteins proved to have similar (though not identicle) human analogs, caspase-9 
and Bcl-2 respectively, that could act in an analogous fashion (Yuan, 1993), 
(Hengartner, 1994). Further studies would illuminate that the family of 
apoptotic/survival proteins were not restricted to certain organisms and that many 
of the proteins in fact played a role in the processes of normal development. 
Homeostasis and physiological health in any cell is reliant on strict and 
precise control of apoptotic mechanisms. For example, damaged or otherwise 
compromised cells are removed by apoptosis for degradation and recovery of 
usable components like amino acids. Apoptosis can also be selectively employed 
in the development of structural features in embryos, such as the removal of the 
membranous webbing between the fingers on hands and feet (Steller, 1995). 
However, the proper balance of cell survival versus cell death must be maintained 
by an organism, or catastrophic damage can be incurred.  
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B. Cell Death Biochemistry 
 
  i) Death Receptor Systems and DISC Formation 
  
Apoptosis is mediated through signals internal and external to the cell. The 
source of the signals vary considerably, but must be able to trigger the series of 
events that collectively represent the process of cell death. There are two well 
described apoptotic mechanisms: the intrinsic and extrinsic pathways. While both 
share certain proteins and biochemical steps, each pathway is initiated and 
regulated in a distinct manner. Which mechanism is employed is often a function 
of what signal is introduced into the cell. The intrinsic, or mitochondrial pathway, 
operates through disruption of the outer mitochondrial membrane and may be 
engaged by viral infection, reactive oxygen species (ROS), and most chemical 
toxicants. This pathway can be activated by external signals such as toxicants but 
the death inducing machinery is contained within the cell. 
Conversely, the extrinsic, or death receptor mediated pathway, relies on 
the interaction between a cell membrane receptor protein and its cognate ligand. 
The common “death” receptors include Fas (APO-1/CD-95), DR4 (TRAIL-R1), 
DR5 (TRAIL-R2), and TNFR (tumor necrosis factor receptor) 1 and 2. Their 
corresponding ligands are FasL, TRAIL (tumor necrosis factor related apoptosis-
inducing ligand), and TNF-α (tumor necrosis factor-α) respectively. For the 
purposes of this dissertation, only the receptor ligand interactions of Fas/FasL and 
TRAIL/DR5 will be discussed in detail.  
Fas and DR5 are trans-membrane proteins expressed on the surface of 
cells targeted for apoptosis (Itoh, 1991), (MacFarlane, 1997). The proteins are 
part of a general category of receptors known as the TNF receptor superfamily 
and contain three conserved domains: a cysteine rich extracellular receptor, a 
trans-membrane region, and a cytoplasmic tail with a sequence known as the 
death domain (DD) (Schulze-Osthoff, 1998). The death domain is necessary for 
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binding an intercellular adaptor protein, Fas adapting death domain (FADD), 
which in turn can bind the apoptotic zymogen pro-caspase-8 (Chinnaiyan, 1995). 
Later studies showed that DR5 also bound FADD during caspase initiation 
(Schneider, 1997) , (Kuang, 2000).  
Fas, a 319 amino acid protein, is an extensively studied death receptor and 
a component of the normal immune response (Itoh, 1991). The Fas/FasL system 
was first observed to induce apoptosis in activated T-lymphocytes (Owen-Schaub, 
1992). The results explained why mice with a mutation in the Fas gene, known as 
lpr (lymphoproliferative) mice, had an increased tendency for auto-immune 
disease and helped to underline a normal function of Fas in the apoptosis of self-
reacting T-cells (Watanabe-Fukunaga, 1992). Fas also mediates cell death 
following various injury models, notably therapies such as radiation. Removing or 
disabling Fas will often lead to tumor growth and cancer (Landowski, 1997), 
(Maeda, 1999), (Mullauer, 2001). Thus, Fas also protects cells from over-
proliferation and its protein levels are positively linked to apoptosis in many cell 
types, including germ cells, and under many different conditions.  
The Fas/FasL system is not the only important death receptor interaction 
in cell homeostasis. The TRAIL/DR5 system is also a key regulator of apoptosis. 
The apparent selective sensitivity of tumor cells to undergo apoptotic cell death 
by exposure to the cytokine TRAIL (tumor necrosis factor related apoptosis-
inducing ligand) has led to considerable speculation as to its potential as a cancer 
therapeutic agent (Kimberley, 2004). In fact, TRAIL is currently being tested in 
human clinical trials for this purpose. (Duiker, 2006). TRAIL has also been 
reported to initiate apoptosis in certain non-transformed or primary cell types, 
including hepatocytes (Lawrence, 2001), (Mori, 2004). However, the underlying 
mechanisms that account for the sensitivity of cells to TRAIL-mediated apoptosis 
remain unsolved and is a topic of intense investigation. One hypothesis is that 
DR5 may act as a “substitute” system when other death receptors, such as Fas, are 
disabled. The TRAIL/DR5 system may be more active in different cell types, such 
as those with high proliferation rates, including the testis. 
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Each receptor-ligand tandem operates in an analogous way to promote cell 
death. Under conditions of apoptosis, Fas or DR5 may be present on the cell 
membrane initially as monomers but soon form homotrimers via association 
through their extracellular PLAD (pre-ligand binding association domain) region 
(Chan, 2000), (Siegel, 2000), (Daniels, 2005). Death receptor association is 
generally described as being trimeric, although the exact number is unknown and 
up to six receptors may associate at once to induce apoptosis (Holler, 2003). In 
the case of Fas, evidence shows that the minimum formation of homotrimers must 
occur or apoptosis is not able to properly initiate (Siegel, 2000), (Papoff, 1999). In 
this case, receptor ligands FasL and TRAIL probably must exist as trimers as 
well, producing a 3:3 stoichiometry upon interaction (Siegel, 2000). Thus, trimers 
of receptor and ligand must be present to activate apoptosis through the extrinsic 
pathway and trigger the first steps in the enzymatic cascade.  
Receptor/ligand complexes stimulate the recruitment of the adapter protein 
FADD to the intracellular death domain of the receptor. FADD shares a N-
terminal death domain complementary to the sequence in the C-terminal region of 
Fas or DR5. This complexation of receptor and adaptor attracts a zymogen called  
procaspases -8 or -10 and binding occurs between the death domain of FADD and 
the N-terminal death effector domain (DED) region of the caspase (Peter, 2003). 
The assembly of all the proteins—receptor, ligand, adaptor, and caspase—form  a 
complex known as the death inducing signaling complex (DISC). The interaction 
of procaspases at the DISC platform allows for their proteolytic cleavage and 
activation of the caspase “cascade” required to initiate apoptosis (Muzio, 1996). 
Death receptors associate on the membrane of the cell through their 
extracellular PLAD region prior to ligand binding, which then activates formation 
of the DISC (Siegel, 2000), (Algeciras-Schimnich, 2002), (Henkler, 2005). The 
formation of the DISC appears to promote aggregation of additional death 
receptor trimers on the cell surface, resulting in clustering and more potent 
apoptosis when the ligand triggers caspase cleavage (Siegel, 2000). The clustering 
sometimes occurs within a lipid raft, a cholesterol and sphingolipid rich region of 
 15 
the cell membrane where many different type of signaling molecules reside 
(Scheel-Toellner, 2002). The generation of concentrated Fas trimer clusters on the 
membrane has been observed when fluorescently stained and observed 
microscopically as “Fas capping.” (Belka, 1998), (Cremesti, 2001) Because DR5 
also likely assembles higher order clusters on the cell membrane, caps 
theoretically can form after conditions of high expression as well. Recently, a 
report has identified increased DR5 association and clustering in lipid rafts with 
high levels of membrane ceramides (Martin, 2005). 
 
ii) Caspases and the Apoptotic Pathways 
 
A myriad of proteins are involved in the initiation, execution, and regulation 
of apoptosis. However, caspases are the proteins central to the process and are an 
absolute requirement for most types of cell death. The fundamental action of the 
caspase is to recognize and cleave target protein molecules after a specific 
aspartic acid residue. Cleavage will usually inactivate, but sometimes stimulate or 
even change the basic function of a given substrate. Apoptosis can occur 
independent of caspases, for example through the activity of apoptosis inducing 
factor (AIF) or lysosomal stress (Kroemer, 2005). However, caspase activation is 
observed in nearly all instances of traditional apoptosis. 
 Currently fourteen human caspase genes have been found. The proteins 
are expressed as  zymogens called pro-caspases, which possess weak enzymatic 
activity. Pro-caspases can be organized based on the length of their N-terminal 
“prodomain” region, which also helps to determine the functional role of the 
protein. Caspases that possess a long prodomain (caspase-1, -2, -4, -5, -8, -9, -10, 
-11, -12) are able to interact with adaptor proteins to promote cell death and are 
designated initiator or apical caspases. As discussed in the previous section, 
TRAIL/DR5 or Fas/FasL triggering requires the adaptor protein FADD. FADD 
molecules possess death effector domains (DEDs) that bind a similar region on 
the N-terminal prodomain of the initiator pro-caspase. FADD also interacts with 
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the death domain (DD) region along the transmembrane tail of the death receptor 
(Chinnaiyan, 1996), (Chen, 2002). The combination of death receptor, adaptor 
protein, and pro-caspase is known collectively as the DISC, or death inducing 
signaling complex. The initiator caspase is most commonly caspase-8, but -10 has 
been shown to localize as part of the DISC for extrinsic apoptotic signaling as 
well (Kischkel, 2001). 
The mechanism of initiator procaspase activation is still being studied. It is 
known that procaspase monomers have weak enzymatic activity (Muzio, 1997). 
Procaspases in the DISC are thought to be activated through cleavage by an 
adjacent procaspase. Although one initiator procaspase is inactive, a complex of 
many together will produce enough catalytic activity that each protein is cleaved 
and rearranged, forming the active conformation. The procaspases are arranged 
close to each other in order to achieve this autocatalytic processing, which is 
referred to as the induced proximity model (Muzio, 1998), (Salvesen, 1999). Once 
activated, the caspase forms a heterotetramer, which can interact with and cleave 
the effector caspases. Effectors represent the second group of proteases with short 
prodomains. Caspases -3, -6, -7, and comprise this group and execute the 
apoptotic program by cleaving important substrates in the cell, such as laminin, 
ICAD, and PARP. A refinement of this hypothesis, known as the unified model, 
argues that simple dimerization of procaspase-8 is sufficient to initiate activation 
(Boatright, 2003). However, both views agree that downstream activation of 
effector caspases is requisite for apoptosis. 
Caspases have the ability to cleave after tetrapeptide motifs (denoted as P4-
P3-P2-P1) when the P1 amino acid is an aspartic acid (Shi, 2002). Interestingly, 
caspases themselves are cleaved at a particular aspartic acid, resulting in the 
formation of large (~20 kD) and small (~10 kD) sub-units, a pro-domain, and a 
linker region (Cohen, 1997). The resulting heterotetrameric structure is 
considered the active form of the protein and this structural rearrangement is seen 
in both initiator and executor caspases. 
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In summary, the death receptor pathway always involves the initial 
engagement of a death receptor and its cognate ligand, activation of caspase-8, 
and the downstream cleavage of effector procaspase-3. The aggregation of death 
receptor-ligand complexes are thought to stimulate DISC formation by attracting 
the adaptor protein FADD and procaspase-8. In the most popular model, the close 
proximity of weakly proteolytic procaspase-8 molecules result in their 
autocleavage and the production of active caspase-8. Only then can caspase-3 be 
completely processed and facilitate the cleavage of cellular substrates that 
culminate in cell death. This process is mitigated by c-FLIP, an inhibitor that 
blocks caspase-8 activation in this process (Fig. 1.4). The function of c-FLIP will 
be fully discussed in the next section. 
Apoptosis can also be generated through the intrinsic pathway (Fig. 1.5) 
Although this mechanism ultimately activates caspase-3, the upstream chain of 
events is much different and considerably more complex. The initiation of 
apoptosis utilizes the BCL-2 proteins Bak and Bax to create a channel in the outer 
membrane of the mitochondria organelle (Luo, 1998), (Korsmeyer, 2000). The 
pore introduced by Bax/Bak is referred to as the mitochondria permeability 
transmission pore (PTP), which accomplishes two events: the abolishment of the 
ordinary voltage potential across the mitochondrial inner membrane and the 
release of the pro-apoptotic molecule cytochrome c. The timing of the loss of 
membrane potential is controversial and may in fact occur post cytochrome c 
release (Gogvadze, 2006). Nevertheless, the PTP extends to the outer membrane, 
triggering the release of cytochrome c and its eventual  integration as a 
component of the apoptosome. The apoptosome is a complex of  ATP, caspase-9, 
cytocrome c, and an adapter protein called Apaf-1. It is well established now that 
this complex is responsible for the cleavage of procaspase-9 into active caspase-9. 
Ultimately, caspase-9 processes caspase-3 and propagates an apoptotic response 
leading to the death of the cell (Li, 1997), (Bao, 2007). 
MEHP-mediated apoptosis is known to primarily stimulate the extrinsic 
pathway, and therefore the above description of intrinsic cell death has been 
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greatly simplified. (For a more in depth discussion of mitochondrial cell death, 
please refer to the following review, {Kroemer, 2003}) It should be noted that 
cross talk does occur between the two pathways. Under conditions of robust 
apoptotic activity in type I cells, caspase-8 activation may also act to cleave the 
BH3-only protein Bid into t-Bid (truncated Bid), acting with Bax/Bak to aid in 
the formation of the mitochondrial transmembrane pore and eventual apoptosis 
though the intrinsic pathway (Luo, 1998), (Scaffidi, 1999). Therefore, death 
receptors may at times induce the mitochondrial pathway if the activation of 
caspase-8 is high enough and Bid is expressed in the same cell. However, in type 
II cells (where caspase-8 activity is low), Bax is the principle activator of the 
mitochondrial pathway of cell death (Scaffidi, 1999), (Barnhart, 2003), (Rudner, 
2005). The two pathways may be regarded as redundant in this manner, as the 
outcome of both pathways is activated caspase-3. 
 
iii) Caspase inhibitors and apoptotic regulation 
 
Given the critical role of caspases, tight regulation of their action is of the 
highest importance. Inappropriate activation of caspases is implicated in 
neurodegenerative disorders such as Alzheimer’s Disease and amyotrophic lateral 
sclerosis, cardiac and liver dysfunctions, and infertility (Malhi, 2006), (Gervais, 
1999), (Gustafsson, 2003). Often chemotherapeutic drugs and treatments engage 
the apoptotic machinery leading to the  death of several tissues. To protect from 
unrestricted apoptosis, the cell has developed tools to combat the expression of 
caspases and prevent widespread death. 
The most important inhibitor of the death receptor mediated pathway at the 
DISC is c-FLIP (FLICE-like inhibitor of protein, also commonly known as c-
FLIP, c-FLAR, Flame, or usurpin), which was first identified in herpesvirus but is 
common to all known mammalian systems (Thome, 1997). c-FLIP mimics the 
structure of procaspase-8 and acts as a competitive inhibitor to that protein. This 
ability is due to the dual N-terminal DED (death effector domains) regions 
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homologous to those of caspase-8 (Fig. 1.4). However, the caspase-like region of 
c-FLIP is missing the catalytic cysteine region that would lead to the complete 
cleavage and activation of caspases (Scaffidi, 1999), (Krueger, 2001). 
Consequently, if expressed highly in the DISC instead of capsases, death 
receptor-ligand complexes will fail to induce apoptosis in most cases.  
The mechanism appears to be one of competition between c-FLIP and 
caspase-8 for the adaptor FADD at the DISC and has been shown to be 
concentration dependent (Chang, 2002). High expression of c-FLIP can lead to 
partial reduction or complete inhibition of caspase-8 dependent apoptosis. The 
inhibition is believed to act by tying up the DED position on FADD and therefore 
inhibiting ongoing activation of procaspases present at the DISC. There is also 
some evidence that FLIP can physically bind procaspase-8 as determined by in 
vitro binding studies in HEK 293 cells (Hu, 1997). Thus, c-FLIP may have more 
than one substrate for which to block death receptor induced apoptosis. 
c-FLIP can be detected as numerous mRNA transcripts but the protein is 
commonly expressed in only two forms, short (~28 kD) and long (~56 kD), 
although a lymphocyte-specific form has also been recently identified (Golks, 
2005). The former is thought to be unambiguously anti-apoptotic and prevents 
cell death by blocking access of procaspase-8 to the DISC. Structural data reveals 
that c-FLIPs possesses a FADD binding region (death effector domain) 
homologous to procaspase-8 but lacks the catalytic domain altogether. Thus, the 
short isoform is not involved with biochemical processing at the DISC and 
functions to saturate procaspase-8 binding sites (Kirchhoff, 2000). 
The long form is less well defined functionally, although most research has 
determined its function to be anti-apoptotic under normal physiological conditions 
(Sharp, 2005), (Tschopp, 1997). c-FLIPL contains a caspase-like prodomain and 
the catalytic domain, although lacking the cysteine-containing active site. 
However, at very low levels c-FLIPL may act to induce apoptosis via 
heterodimerization (Boatright, 2003). In the proximity model, homotrimeric 



























Fig. 1.4 DISC formation and the mechanism of the extrinsic pathway. Death 
receptor/ligand complexes recruit FADD and procaspase-8 to the membrane, 
which then activates downstream caspase-3 activation and cell death. The process 























































Fig. 1.5 Apoptosome formation and mechanism of the Intrinsic Pathway. Bak and 
Bax act to induce a pore in the outer membrane of the mitochondria, triggering 
cytochrome C release. The interaction of ATP, the adapter protein Apaf-1, and 
procaspase-9 constitutes the apoptomsome, leading to caspase-9 activation and 
cell death. XIAP functions to bind caspases and prevent their activation, thus is a 
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However, several reports have indicated that heterogeneous complexes of capase-
8 and FLIPL may also trigger apoptosis under certain conditions or concentrations 
(Chang, 2002). This effect has been seen, for instance, in the augmentation of cell 
death in the T-cells (Dohrman, 2005).  It is known that both c-FLIP and caspase-8 
undergo proteolytic processing when mixed at the DISC, but in most reported 
cases the processed form of c-FLIPL (p43) inhibits further activation after an 
initial cleavage step. Therefore, the mechanism of c-FLIPL protein remains 
controversial. 
Both c-FLIP short and long may be important to the survival of germ cells 
stressed by MEHP. The protein, particularly c-FLIPL, has been detected in germ 
cells and protects them from  death in response to apoptotic stimuli (Giampietri, 
2003). c-FLIPL inhibits Fas and TRAIL mediated apoptosis in germ cells; the 
mechanism of action may partly be under control of p53, which has been 
suspected to increase death receptor levels to a point that c-FLIP can no longer 
provide protection (Chandrasekaran, 2005). The germ sub-type most effected by 
MEHP exposures is the spermatocyte, located in the adluminal compartment. 
Whether the c-FLIP is degraded to facilitate spermatocyte apoptosis is unknown. 
The regulation of this interaction may be important to the increased production of 
spermatozoa in toxicant-affected testis. 
Another major class of caspase inhibitors are the inhibitor of apoptosis (IAP) 
family. As with c-FLIP, the discovery of the first IAP genes were derived from a 
virus species, bacculovirus (Crook, 1993). The protein was initially shown to 
impart protection against apoptosis in insects infected with the virus. However, 
various homologs exist across a variety of species, including Drosophila, C. 
elegans, yeast, and mammals. Mammals express c-IAP-1/2, survivin, and XIAP 
in a largely ubiquitous manner (Deveraux, 1999). Specialized transcripts, such as 
ILP-2 in the testis, have also been detected (Richter, 2001). 
XIAP (X-chromosome-linked inhibitor of apoptosis protein) is the most 
studied of the IAP’s and is considered the most potent inhibitor of cell death. In 
fact, the protein binds its target substrates more tightly at lower concentrations 
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than other members of the IAP family (Deveraux, 1999). Part of the reason is that 
unlike c-FLIP, the XIAP protein is able to effectively block caspase-3, the 
effector caspase for both the mitochondrial pathway and the death receptor 
pathway of apoptosis. In addition, XIAP can specifically bind and neutralize 
caspase-9, the initiator caspase for the mitochondrial pathway. XIAP regulatory 
proteins possesses three distinct regions called BIR’s (bacculoviral inhibitor of 
apoptosis repeats) that denote their binding specificity. The interaction between 
XIAP and caspases are thought to be largely mediated by the BIR regions and 
apoptosis is blocked by reduced access of the caspase to its substrate (Bratton, 
2002). BIR-2 and a portion of a preceeding linking sequence bind caspase-3 and 
BIR-3 binds caspase-9.  
Additionally, XIAP contains a c-terminal RING (really interesting new gene) 
domain and functions as an E3 ubiquitin ligase. E3 ligases are the final executors 
of ubiquitinylation, one of the most common types of post-translational protein 
modifications (Suzuki, 2001). E3 ligases are designed to add ubiquitin molecules 
onto the target proteins, which are then “marked” for cellular transport, 
endocytosis, or degradation by the proteasome. In this last instance, caspases and 
other cellular targets may be actually be removed by degradation in addition to 
being bound and sequestered by a given XIAP, although this theory remains 
speculative (Yang, 2000).  
Interestingly, XIAP can also autoubiquitinylate. This self limiting step is 
another way in which the protein is designed to control overexpression. In 
addition, antagonists smac/diablo are released from the mitochondria and prevent 
inappropriate activity of XIAP by competing for the same binding sites that 
caspases occupy (Du, 2000), (Verhagen, 2000), (Srinivasula, 2000). The agonistic 
activity of smac/diablo is supplemented by Omi/htr2A, a mitochondrial protease 
that is believed to also compete for XIAP binding sites and possibly degrade the 
XIAP protein itself (Martins, 2002). However, the RING finger of XIAP is 
capable of ubiquitinylating these proteins as well (MacFarlane, 2002). Whether 
XIAP and its inhibitors are actively engaged following MEHP-induced apoptosis 
 24 
is unknown; the toxicant has been shown to only weakly activate the intrinsic 
pathway and additional studies will be necessary to elucidate the role of XIAP. 
The process of  ubiquitinylation and its role in regulating apoptosis will be further 
discussed in regards to c-FLIP, which may be sensitive to E3 ligases. 
Another major group of apoptosis regulators are the BCL-2 family of 
proteins. Extensive research has been undertaken to define these modulators, 
which can be pro-apoptotic (Bak, Bax, Bad, t-BID, among others) or anti-
apoptotic (bcl-xl, bcl-2, bcl-w). The key to their activity resides in the particular 
BH (BCL homology) domains. The apoptotic BCL-2 family members can be 
activated by DNA damage, radiation, and chemical stresses, and often operate in 
conjunction to form pores in the mitochondrial outer membrane. For example, t-
BID formation promotes Bak oligimerization, which can then work in conjunction 
with Bax (Wei, 2000), (Korsmeyer, 2000). Together, they form the upstream 
component of the mitochondrial apoptotic pathway and aid in the release of 
cytochrome c following the destabilization of the organelle’s membrane and  
ultimately the formation of the apoptosome. The survival protein BCL-2 inhibits 
this process by antagonizing Bax and preventing the destabilizing pore in the 
mitochondrial membrane. (For a comprehensive review, please refer to 
{Walensky, 2006})  
 
1.3 Phthalates and Testicular Toxicity 
 
A. DEHP and MEHP 
 
MEHP (mono-2[ethylhexyl]-phthalate) is a major metabolite of 
plasticizing agent DEHP (di-2[ethylhexyl]-phthalate) that is found widely 
dispersed throughout the environment (Koch, 2006). Phthalates such as DEHP are 
used to soften plastics and lend to them a range of flexibility. The chemical is 
extremely widespread due to its use in polyvinylchloride (PVC) pipe as well as in 
plastic bags, food packs, and upholstery. In addition, phthalates are used in a 
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variety of solvents, oils, and adhesives. A more extensive list of phthalate 
containing products can be found in the comprehensive report written by the 
Center for Evaluation of Risks to Human Reproduction (Kavlock, 2002). 
DEHP is not covalently bound to its plastic constituents and therefore 
loses contact with them over time. The primary route of exposure in humans is 
through ingestion, as DEHP concentrations contaminate drinking water and 
foodstuffs. Infants are often the most sensitive population, as bottles and pacifiers 
leach small levels of phthalate over time. Routine human consumption can be as 
high as 30 µg/kg/per day and 3.3 µg/kg/per day in infants , legitimizing concerns 
over exposure to phthalates (Albro, 1984).  
DEHP is a di-ester acid that undergoes hydrolysis when metabolized and 
generates a mono-ester, MEHP, and several alcohol products (Fig. 1.6). However, 
MEHP is the most potent metabolic by-product in regards to testicular toxicity, 
probably because of its relatively high half-life in the testis. Ingestion of the 
DEHP compound produces different effects according to dose and species. In 
general, mammals experience dysfunction in the liver and reproductive tissues, 
including the testis. Rodent hepatocytes are particularly sensitive to DEHP 
metabolism and exhibit increased peroxisome proliferation (Gray, 1983). 
Occasionally MEHP has also been indicated in carcinogenesis, but only at 
extremely high and prolonged doses.  
However, MEHP is of particular interest due to its effect on germ cell 
health and fertility. The compound has been shown in numerous studies to be 
associated with testicular apoptosis, morphological defects, and increased 
infertility (Gray, 1980), (Latini, 2006). These reasons, as well as its ubiquitous 
presence in the environment, justify the use of MEHP as a means to study the 






B. MEHP and Testicular Injury: A Model 
 
MEHP is in appropriate choice for modeling testicular cell death for 
several reasons. Physiologically, MEHP exposure induces testicular abnormalities 
such as lower testicular weights, loss of germ cells, vacuolization, and hormone 
secretion (Richburg, 2002), (Richburg, 2003). However, MEHP is also thought to 
specifically target the Sertoli cell. In doing so, the health of germ cells dependent 
on Sertoli cell health will be indirectly damaged as a result; MEHP toxicity is 
known to interfere with proper growth factor release, disruption of hormonal 
balances, and the induction of pro-apoptotic ligands specific for germ cell 
membranes (Boekelheide, 2005). However, Sertoli cells rarely die as a result of 
direct MEHP toxicity and are known to remain robust in response to even very 
high toxic exposures (Richburg, 2002). Hence, MEHP causes a cellular “stress” or 
damage that transiently effects Sertoli cell homeostasis. The loss of the cell’s 
stability in turn results in lower germ cell support capacity (Fig. 1.7). Phthalates 
have been implicated in numerous testicular and spermatogenic abnormalities: 
cryptorchidism (failure of the testes to descend), testicular cancer, and low sperm 
count. Several symptoms combined is referred to as testicular dysgenesis (TDS). 
TDS has been linked with failure of spermatogenesis, followed by reduced mature 
sperm numbers and infertility (Sharpe, 2001), (Fisher, 2004). 
DEHP is reduced to MEHP via hydrolysis in the stomach and intestines in 
mammals (Albro, 1989). A possible reason why MEHP maintains such high 
toxicity in the seminiferous tubules can be attributed to its lipophillic character, 
which extends the duration the toxicant can spend in the testis. However, the 
sensitivity of the toxicant is variable among animals, with rodents the most 
sensitive and monkeys the least. Rodents appear to be unable to further 
metabolize MEHP, leading to their long-term presence in the testis, commonly a 
two day half-life (Oishi, 1982). Most humans actively glucoronidate MEHP  to 
water soluble by-products and are able to excrete the toxicant. An important 


























Fig. 1.7 DEHP Products. DEHP is metabolized into two major products via 
hydrolysis, MEHP and 2–ethylhexyl phthalate. MEHP is lipophillic, so the 
compound is glucoronidized in the liver to make it more water soluble, allowing 
excretion through urination. Infants under the age of four months do not have this 
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Fig. 1.7. MEHP and germ cell homeostasis. Proliferation or apoptosis of germ 
cells is determined by the status of the Sertoli cell. MEHP treatments push the 









environmentally exposed to the compound via bottled formula and pacifiers 
(Lottrup, 2006). 
Acute doses of 1g/kg by oral gavage are sufficient to induce significant 
morphological changes in Sertoli cells as early as three hours. Although 
significantly higher than ordinary human exposures, the dose is useful in 
determining gross changes in effected tissues and to study its mechanism of 
action. Vacuolization of the seminiferous tubule is an early indicator of germ cell 
damage and later stages exhibit Sertoli cell retraction (“flattening”) along the 
basement membrane and significant apoptosis in spermatocytes and spermatids.  
Changes in Sertoli cell morphology suggest that it may be the direct target 
of MEHP. For example, the Sertoli cell intermediate filament vimentin is affected 
by treatments, resulting in a structural derangement that leads to germ cell death 
(Richburg, 1996). Biochemical products such as lactate and pyruvate are also 
altered when MEHP is added to Sertoli cell cultures, effecting their energy 
producing and secretory functions, while germ cells appear to be uneffected 
(Williams, 1989). Despite these effects, Sertoli cells may stop proliferating but 
rarely die (Boekelheide, 1991). Developmental data has shown that chronic 
exposure to MEHP slows their initial proliferation of Sertoli cells and reduces 
their number per tubule (Dostal, 1988). However, damage to Sertoli cells 
represents a particularly important factor in the death of germ cells above the tight 
junctions that separate the basal and adluminal compartments. Extented MEHP 
exposures can reduce or damage Sertoli cell populations enough to eventually 
deplete the tubule of all but the earliest germ cell populations (such as stem 
spermatogonia), underlining the importance of  Sertoli cell participation in 
spermatogenesis. 
 Investigations into the mechanism of MEHP toxicity have shown a 
myriad of testicular alterations post exposure. Zinc deprivation, competition for 
FSH receptors, and interference with steroid production have all been put forth as 
possible reasons for toxicity (Boekelheide, 2005). MEHP in adult rodents have 
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shown the highest level of testicular damage in the stages that FSH is the most 
highly expressed, suggesting a possible molecular target for toxicant within the 
Sertoli cell (Grasso, 1993). The PPAR (peroxisome proliferation-activated 
receptors) family of receptors has also been considered as a target, given the 
ability of MEHP to induce peroxisome formation in the liver (Braissant, 1998) 
However, no one hypothesis has produced a definitive answer as to what the 
actual mechanism may be.  
 Another possibility is related directly to the physical interaction of germ 
cells and Sertoli cells. As aforementioned, Sertoli cells are designed to provide 
support and organization to germ cell populations. Lacking this proper 
architecture, spermatogenesis is impaired. Physical detachment of Sertoli cells 
from germ cells in co-cultures can initiate cell death at lower levels than required 
for morphological changes (Gray, 1984). Various sources have compiled evidence 
that the disruption between these two cell types will lead to the apoptotic 
mechanism (Dirami, 1995), (Sawhney, 2005). 
To date, no papers have definitively shown whether MEHP acts though the 
extrinsic or intrinsic apoptotic pathway. Some light background levels of 
activated caspase-9 can be detected post-MEHP treatment, suggesting the protein 
is involved. However, evidence strongly favors the extrinsic pathway, particularly 
in regards to the production of death ligands and their receptors in cells that have 
been damaged or “stressed” by the toxicant. One further note concerns the 
distinction between whether germ cells preferentially undergo extrinsic (type I) or 
intrinsic (type II) apoptosis. Type I cells respond to the addition of death receptors 
by formation of the DISC complex and activation of large quantities of caspase-8. 
Type II cells activate only enough caspase-8 to cleave Bid into t-Bid and to 
reinforce the cleavage of procaspase-3 (Scaffidi, 1999). 
The classification of germ cells as either type I or type II is ambiguous and 
controversial. As a heterogenious population in the testis, each germ cell type may 
in fact have a different classification. Spermatogonia, one of the earliest germ cell 
sub-types, is relatively insensitive to death receptor stimulation and requires the 
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BCL-2 protein Bax to undergo apoptosis (Russell, 2002), (Sugiyama, 2001). In 
contrast, spermatocytes appear to be very sensitive to death receptors while the 
intrinsic pathway remain unengaged (Lizama, 2006), (Giammona, 2002). 
However, the apoptotic strategy of these cells remains unsolved and which 
pathway involved may in fact be a function of the toxicant used. For example, the 
chemotherapeutic drug cisplatin generates mitochondrial apoptosis in both 
spermatocytes and spermatogonia (Zhang, 2001). To this point, MEHP has been 
seen to strongly induce the death receptor pathway in spermatocytes, thus a type I 
response is observed. 
The engagement of apoptotic signaling programs in response to Sertoli 
cell stress is one of the principle reasons for employing MEHP in the laboratory. 
The Sertoli cell plays an essential role in controlling germ cell numbers and any 
damage can produce apoptosis. This induction of cell death has been suggested to 
drive germ cell eradication following environmental exposures of phthalates and 
therefore promote infertility in mammalian males. How this is accomplished is 
still undetermined and subject to considerable scrutiny. MEHP challenges were 
developed to elucidate what apoptotic pathways are induced following germ cell 
death and to better understand the mechanisms of cell death in testicular tissues. 
 
1.4 MEHP-mediated Signal Transduction in Germ Cells 
 
MEHP has been used for industrial purposes for more than sixty years. 
However, only in the last twenty years has study of the toxicant been seriously 
investigated in the reproductive tissues. Because MEHP is both ubiquitous in the 
environment and a known testicular toxicant, the study of its mechanism is special 
significance in the field of reproduction. Low fertility is the most common 
physiological outcome of both chronic and acute exposure, but the pathway 
leading to these outcomes remains unknown. A clue to the mechanism of 
infertility lies in the apoptosis observed in germ cells following MEHP exposure. 
Expression of certain proteins have been shown historically to modulate the 
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fundamental balance between apoptotic and survival pathways. Elucidating which 
of these factors are most involved has been the aim of much research in our and 
other laboratories.  
 
A. The Influence of p53 on Germ Cell Apoptosis 
 
The regulatory gene and transcription factor p53 may be the most 
important single agent in the development of tumor production and cancer. In 
fact, data compiled suggests that p53 alterations are present in 50% or more of all 
human cancers (Lavin, 2006). The correlation with cancer is not surprising given 
the wide range of processes mediated by the expression of the gene, from 
transcription of genes in the nucleus to direct binding of cellular substrates. 
Mutation, over-expression, or deletion of the gene and its protein product result in 
the dysfunction of a wide range of critical cellular processes, including DNA 
repair, cell cycle control, stress signaling, and apoptosis (Bargonetti, 2002). 
The structure of p53 reveals insights as to why the protein plays such a 
major role in the maintenance of homeostasis of the cell. The gene encodes a 393 
amino acid protein with three major regions: a transactivation domain (TA), a 
central binding domain (CBD), and a regulatory domain (REG). (Fig. 1.8) Each 
domain confers a different role important in establishing the functionality of p53. 
The CBD is used to associate with specific DNA sequences for transcription of 
target genes and recognizes the inverted repeat sequence 
PuPuPuC(A/T)(A/T)GPyPyPy. This region composes the largest segment of the 
protein (a.a. 100-300)  and also exhibits the highest level of  loss of function 
mutations (Resnick-Silverman, 2006). The transactivation region is involved in 
the binding of transcription machinery and the co-factors required for specific 
gene targeting and transcription (Reed, 1993). The c-terminal regulatory region 
possesses a nuclear localization sequence that allows the protein to shuttle from 
the cytoplasm into the nucleus as well as a tetramerization domain required for 

















Fig. 1.8. p53 structure. Contains three major domains: 1) transactivation domain, 
responsible for binding transcription machinery. This domain’s specificity is 
controlled by various phosphorylation sites. For example, phospho-serine 15 and 
20 have been shown to prevent binding of p53 inhibitor, MDM-2. 2) The DNA 
binding domain, which controls the actual binding of p53 to its DNA substrates 
and is known to frequently contain mutations. 3) The regulatory region contains a 
tetramerization domain that assists in various protein-protein functions and a 
nuclear localization domain. Like the transactivation region, these c-terminal 
domains are regulated through various post-transcriptional modifications, 
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Because of the variety of roles that p53 potentially plays in the cell, strict 
regulation is a necessity. All domains of the p53 protein possess at least one site 
of post-translational modification, such as for phosphorylation, acetylation, 
sumoylation, or ubiquitinylation. The p53 protein has a short half-life and is kept 
at low levels under normal conditions unless a cellular stress is detected. The 
double minute 2 protein (MDM-2) is probably the best known regulator of p53 
activity (Haupt, 1997), (Momand, 1992). This protein is capable of mediating 
ubiquitin addition to substrate proteins with a RING ligase and in conjunction 
with its constituent E2 conjugating enzyme (Oliner, 1992). MDM-2 binds the N-
terminal transactivation domain of p53 and adds a string of ubiquitins to “tag” the  
protein for proteolytic degradation. (Barak, 1993), (Haupt, 1997). 
Phosphorylation at specific serines present in this region inhibit the action of 
MDM-2 and stabilize p53 (Shieh, 1997). These modifications vary by cellular 
stress (such as heat shock versus ionizing radiation), although phosphorylation of  
p53 serines 15 and 20 (serine-18 in mice) are known to specifically prevent 
MDM2 binding (Shieh, 1997). Phosphorylation and acetylation in the C-terminal 
regulatory domain may also inhibit degradation of p53 or possibly effect its 
nuclear import/export signals. As with phosphorylation, it is likely that the 
particular type of stress plays a role in which modifications are made and when. 
Various reports have identified the activity of p53 in the initiation of 
intrinsic apoptosis by influencing the expression or activation of the pro-apoptotic 
bcl-2 family proteins, such as Bax (Miyashita, 1994), (Miyashita, 1995). Bax is 
one of several pro-apoptotic proteins able to localize to the mitochondria and 
cooperate in the formation of a permeabilization pore in the organelle’s outer 
membrane, allowing cytochrome c release. A pair of proteins, noxa and puma, 
may assist in the activity and localization of bax to the mitochondria (Haupt, 
2003). The genes for all three proteins contain p53 response elements and are 
transcribed upon UV or genotoxic stress, supporting an important role in response 
to DNA damage. Demonstrating the complicated nature of apoptotic regulation in 
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cells, p53-dependent apoptosis can also be regulated by the over-expression of 
anti-apoptotic protein BCL-2 in virutally all cell lines (Wang, 1993). 
The regulation of p53, tumorigenesis, and apoptosis are intrinsically 
linked. Radiation, DNA damaging agents such as etoposide, and hydrogen 
peroxide are examples of genotoxic stress agents that promote cell cycle 
catastrophe and promote apoptosis. p53 is engaged and stabilized under these 
conditions, often through phosphorylation of the transactivation domain, leading 
to the transcription of genes in the apoptotic pathway. The mutation of p53 can 
prevent transactivation of certain pro-death genes charged with preventing 
unchecked growth. As a result, cell cycle checkpoints are ignored, leading to 
tumorigenesis in the effected tissues. To abrogate this effect, apoptosis is 
employed to limit uncontrolled, or metastatic, cell growth. Bax, Noxa, Puma, Bid, 
and Apaf-1 are examples of proteins transcribed by p53 in response to genotoxic 
stress (Schuler, 2001). Many of these gene products are active in the 
mitochondrial-mediated pathway. p53 activation/stabilization in the nucleus will 
trigger expression of these proteins, leading to destabilization of the outer 
mitochondrial membrane, the release of cytochrome C, and formation of the 
apoptosome.  
However, p53 is not only involved in cancer or DNA-damage scenarios. 
Non-genotoxic stresses can stabilize the protein as well, including toxicants and 
certain chemotherapeutic agents, leading to the up-regulation of pro-death 
receptors in the extrinsic pathway such as DR5 and Fas. Previous research has 
established that both death receptors contain p53 response elements that induce 
their transcription (Owen-Schaub, 1995), (Wu, 1997). However, the conditions 
specific for cell death are variable according to cell type and injury model, as are 
death receptor/p53 relationships. For example, the thymocytes of gld (FasL 
mutant) mice undergo p53-mediated apoptosis despite lacking a fully functional 
Fas/FasL system (O'Connor, 2000) In contrast, ionizing radiation increases p53 
stability and leads to higher levels of Fas-dependent apoptosis in germ cells 
(Embree-Ku, 2002). Heat shock applied to whole testis also engages the Fas-FasL 
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system and further established a relationship with p53 activity and the death 
receptor expression (Miura, 2002). Germ cells express high levels of both death 
receptors after MEHP-mediated cellular stress and that this may be the result of 
p53 activation. 
There is some evidence suggesting a mechanism by which p53 aids the 
shuttling of Fas from the Golgi to the membrane (Bennet, 1998). A recent study in 
our lab showed that p53 may influence the levels of both Fas and DR5 by 
increasing protein movement to the cell membrane. In this model, p53 deficient 
animals showed reduced death receptor levels on germ cell plasma membrane 
surfaces and a predicted decrease in apoptotic sensitivity. (Chandrasekaran, 2005) 
The study suggests that Fas transcription is not the only method to elevate Fas 
membrane concentrations and that p53 stabilization could be involved in protein 
trafficking as well.  
The multi-functional character of p53 is one of the initial aims of the 
following dissertation, which seeks to understand the relationship between pro-
apoptotic proteins (particularly death receptors) and their downstream modulators 
(c-FLIP). The regulation and function of p53 is very complex and is involved in 
numerous cellular pathways. The supposition here is that p53 can play a role in 
sensitizing germ cells to death after MEHP-mediated Sertoli cell injury. Whether 
the signal is initiated by the withdrawal of a growth factor or another messenger is 
unknown. Nevertheless, p53 is believed to be a critical component to germ cell 
death and appears to effect the expression of pro-death elements following 
cellular stress. 
 
B.  Death Receptor Expression  
 
Sertoli cells have been shown to release death ligands in addition to 
growth factors and previous investigations have revealed that the death receptor 
mediated pathway may be important in response to MEHP exposure. Lee et al 
showed that MEHP administration in adult rats led to an increased expression of 
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FasL from the Sertoli cell and a concomitant increase in Fas receptor in the germ 
cells. Therefore, the germ cells supported by adjacent effected Sertoli cells were 
subject to apoptosis (Lee, 1999) Another experiment tested the apoptotic levels of 
germ cells following MEHP using FasL mutant mice (gld). Gld mice have a 
mutation in the c-terminal region of the FasL protein, preventing efficient binding 
to its substrate, Fas (Takahashi, 1994). The reduced sensitivity to MEHP suggests 
that the toxicant preferentially acts through the death receptor mediated pathway 
and the experimental result confirms that the Fas/FasL system plays a role in 
germ cell apoptosis. However, it also illustrates that simple abrogation of one 
apoptotic protein is not enough to completely inhibit the apoptotic pathway 
(Richburg, 2000). In fact, gld mice exhibit only moderate changes in testicular 
morphology and are fertile. Further data suggested that other death receptors, such 
as DR5 (TRAIL R2), were also expressed after MEHP challenges (Giammona, 
2002). The essentially normal phenotype of the mice would imply the possibility 
of a redundant death receptor system such as the TRAIL/DR5 tandem. 
 The TRAIL/DR5 system is particularly interesting in studies of the 
extrinsic pathway. Like Fas, DR5 is a TNF family member and type II 
transmembrane protein able to stimulate apoptosis via interaction with a death 
receptor (el-Deiry, 1998). The active receptor is DR4 or DR5 in most mammalian 
systems although there also exists two truncated “decoy” forms of DR5 that are 
expressed in certain tissues but are unable to induce apoptosis due to a truncated 
cytoplasmic tail region (Sheridan, 1997).  Decoy receptors have been suggested as 
a way for the immune system to differentiate between normal and over-
proliferative cell types (Kim, 2000). The cytoplasmic region of DR5 receptors 
possess two death domains that are similar in homology to that of Fas and 
function to recruit the FADD adaptor molecule (LeBlanc, 2001). TRAIL is also a 
TNF-alpha family transmembrane protein and serves as its cognate ligand for 
DR4/5. Like Fas, DR5 can form trimers as well as be solubilized by cleavage 
from the cell surface (Wu, 1997). The complex of TRAIL with active DR5 
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triggers apoptosis in a manner homologous to Fas/FasL and acts to initiate the 
extrinsic caspase cascade required for cell death. 
However, unlike Fas, TRAIL is usually active only in tumor or 
transformed cells. This affinity for cancer cells versus normal healthy cells have 
made the protein a promising aid in combating tumorigenesis, although clinical 
trials have had mixed results (Duiker, 2006), (Gajewski, 2007). The TRAIL/DR5 
system is not commonly expressed in physiologically normal cells but there are a 
few notable exceptions, such as in hepatocytes and possibly in the reproductive 
tissues (Mori, 2004). Protein and mRNA levels of TRAIL and DR5 are highly 
expressed in both human and mouse testis. TRAIL is especially high in the Sertoli 
cells and Leydig cells, whereas the expression of the death receptors appear to be 
variable among germ cell type to age specificities (Grataroli, 2002). There is 
evidence that MEHP exposure leads to an increase in DR5 levels in gld mice, 
presumably to replace the reduced function of FasL in facilitating apoptosis.  
The particular distribution of death receptors and their ligands is an 
important question in how germ cells are regulated using programmed cell death. 
The receptor is  an absolute requirement for cells to be sensitive to the extrinsic 
pathway of  apoptosis. In rare cases, the ligand is released from an adjacent cell, 
although some cell types can produce their own autocrine death ligands. 
Cytotoxic T-cells are an example of a cell that expresses both a death receptor and 
its cognate ligand (Dhein, 1995). However, other cells are unresponsive to  the 
presence of death receptors. Spermatogonia, for example, express DR5 but are 
impervious to apoptosis in the presence of TRAIL (Lizama, 2007). 
Spermatocytes, on the other hand, are shown to be very sensitive to both FasL and 
TRAIL expression. Because of the importance of death receptor-mediated 
apoptosis following MEHP exposure, an understanding of germ cell specificity 
and timing is critical.  
However, the nature of death receptor activation in germ cells post-MEHP 
remains an unanswered question. Direct injury to Sertoli cells has been reported, 
concomitant with death ligand increases, but MEHP does not alter the germ cells 
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themselves in a specific and immediate way. Instead, the injury imposed upon the 
Sertoli cell “stresses” germ cell populations, whether by retraction of a growth 
factor or some another signal, leading to higher levels of death receptors on the 
their cell membranes. An important signal in germ cell apoptosis may be the 
activation of p53, followed by the transcription, trafficking and clustering of death 
receptors. The mechanisms downstream of this stress and the specific cells in 
which these mechanisms act composes the bulk of this dissertation.   
 
C.  The Role of Ubiquitinylation in FLIP Regulation 
 
The activity that occurs at the DISC will determine whether of not 
apoptosis occurs through the death receptor mediated pathway. As discussed in 
the previous section, the accumulation of death receptors on the cell membrane 
are thought to promote the assembly of the DISC components at the membrane 
and initiate the apoptotic cascade. Like other steps in the apoptotic pathway, a 
fundamental balance between death and survival proteins is observed. At the 
DISC, once formed, that balance is influenced by the ratio of procaspase-8 
molecules and their direct inhibitor, c-FLIP. Which protein is found in the highest 
concentration at the DISC is thought to an important determinate of whether 
apoptosis proceeds from this point or is blocked.  
The place that c-FLIP occupies in apoptosis is sometimes uncertain. The 
short form (c-FLIPs) is thought to be unambiguously anti-apoptotic and has been 
shown to completely block caspase-8 cleavage at the DISC (Bin, 2002), (Krueger, 
2001). The mechanism is thought to be mediated by the direct binding of the 
molecule to the DED of FADD in a competitive saturation of caspase-8 binding 
sites. FLIPL is believed to interact in much the same way, although the protein 
contains a caspase-like pro-domain that can be cleaved at Asp-341 (Thome, 
2001). This enables c-FLIPL to be processed once in a fashion similar to 
procaspase-8, although the processed form is thought to remain at the DISC as an 
effective block to apoptosis. However, the ability for procaspase-8 and FLIPL to 
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form heterodimers at the DISC has produced conflict within the literature. The 
possibility that heterodimers act to increase procaspase-8 cleavage has been 
reported and seems to be concentration dependent. There is also evidence that 
FLIPL – mediated procaspase cleavage may increase apoptosis via the processing 
of other caspase substrates in the DISC, such as receptor interacting kinase (RIP) 
(Boatright, 2004), (Micheau, 2002). 
In the testis, c-FLIP levels have been identified with cell survival 
(Giampietri, 2003). However, relatively little research has been completed on the 
role of FLIP in germ cell populations and few have examined its regulation. A 
seminal paper by Fukazsawa et al suggested that c-FLIP may be targeted for the 
degradation in cancer cells when proteasome inhibitors blocked a decrease in the 
protein following p53 dependent apoptosis (Fukazawa, 2001). Both proteins show 
changes in concentration after MEHP treatment in the testis. The presence of p53 
and c-FLIP within the same regulatory pathway suggests a link between the two 
in germ cell apoptosis. 
Following the initial Fukazawa paper, ubiquitinylation has been associated 
with the regulation of the c-FLIP proteins. Both c-FLIPL and c-FLIPs undergo 
quick turn-over in the cell (four hours for FLIPs, if treated with CHX); 
particularly FLIPs, which has shown to be susceptible to the ubiquitin pathway 
due to target recognition residues on its c-terminus (Golks, 2005), (Poukkula, 
2005). To date, no such region has been identified on the long form. The change 
in relative half-life between the two isomers is among the interesting differences 
between two proteins that share extensive homology. The c-FLIPL and c-FLIPs 
are known to act at the DISC but new evidence suggests that the long form may 
possess regulatory functions that have yet to be elucidated. For example, c-FLIPL 
has shown an unexpected activity in lymphocyte proliferation (Lens, 2002). The 
last aim of this dissertation is to shed light upon the role that c-FLIP plays in germ 
cells and to understand how the protein is ultimately regulated. Since c-FLIP 
potentially holds the key to whether a germ cell lives or dies, the key to 


























Fig. 1.7 The Ubiquitin-Proteasome System. Loose ubiquitin is covalently bound 
to the E1 enzyme via ATP and transferred through the intermediate E2 before 
target specificity is determined by the E3 ligase. Whether the target is fated for 















Ubiquitinylation is the process of post-transcriptionally modifying 
proteins targeted for a cellular process. This is accomplished by covalently adding 
small (~8 kD) proteins called ubiquitin onto exposed lysine moieties in a given 
protein. The mechanism of individual ubiquitin molecule transfer occurs via three 
distinct enzymes: E1 (activating),  E2 (conjugating), and the E3 (ligase) (Fig. 
1.7). The activation process is ATP-dependent and biochemically requires the 
formation of a thiol ester between the c-terminal glycine of ubiquitin to a 
substrate lysine (Hochstrasser, 1992). Conjugation is an intermediate step, 
mediated by an E2 ligase, which involves passing the activated ubiquitin to an E3 
ligase, for direct attachment to the targeted protein (Hershko, 1992). The E1 
enzyme is a highly conserved enzyme and usually exists as only one or two 
varieties among individual organisms whereas E2 and E3 can be found in more 
varieties. The E3 enzyme is divided into two families (HECT and RING) but both 
aid in physically ligating ubiquitin molecules onto lysine residues. The RING 
ligase varies somewhat from HECT domains because it works together with the 
E2 conjugating enzyme to ubiquitinylate target substrates (Ingham, 2004). The 
HECT ligase directly attaches ubiquitin unaided.  
The ultimate target of the ubiquitin labeled protein is the proteasome, 
located in the cytosol of all cells. The 26s proteasome is multi-subunit complex 
(~2000 kD) that cleaves apart ubiquitin-protein conjugates with the use of ATP. 
Inhibition of the proteasome is a component of some chemotherapies and is 
commonly accomplished with compounds such as lactacystin, which blocks 
chemotrypsin activity (Kornitzer, 2000). However, in many cases proteasome 
inhibition effects proper clearing of other molecules, and addition to germ cell 
cultures leads to massive cell death.  
The function of ubiquitin relies on two factors: 1) which lysine is 
thilolated on the protein and 2)  how many ubiquitins are strung together through 
that thiolation. If four or more ubiquitins are added to any one lysine (usually 
K48) then that protein is targeted to the proteasome for degradation. This process 
is referred to as poly-ubiquitinylation. However, thiolation of K29 or K63 are 
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known to support other fates for the cell. For instance, DNA damage repair occurs 
when K63 is ubiquitinylated (Pickart, 2001),  (Hofmann, 2001). Sometimes 
proteins are also mono-ubiquitinylated on different lysines, resulting in changes in 
protein trafficking, endocytosis, vesicle formation, and other functions (Haglund, 
2003). 
An increasing amount of evidence suggests that c-FLIP levels are 
maintained through ubiquitinylation (Fukazawa, 2001), (Poukkula, 2005), 
(Chanvorachote, 2005). However, the E3 ligase responsible for its degradation is 
unspecified. One possibility is the HECT E3 ligase Itch, which is a component of 
T-cell cytotoxicity and regulation. The Itch protein has been implicated in 
targeting c-FLIP for degradation in liver cells (Chang, 2006). Further studies of 
Itch may help unravel the role of c-FLIP in germ cell apoptosis. 
Although the ubiquitin pathway has been extensively described, little has 
been published in regard to its function in germ cell death or survival. However, 
given the importance of FLIP to controlling the death receptor-mediated pathway, 
an evaluation of its ability to undergo post-translational regulation is germane to 
our research. In addition, death receptors as well as germ cell death may be under 
the control of the p53 protein. In fact, experiments with p53-/- mice have shown a 
reduced amount of cell death and Fas expression, with a correlative increase in c-
FLIP levels (Chandrasekaran, 2005). However, many components of germ cell 
specificity, c-FLIP processing at the DISC, and FLIP regulation are all currently 
unresolved. By using the stress-inducing environmental toxicant MEHP, these 
questions can be answered. In doing so, the mechanism of germ cell death will 
allow greater insights into how the testis respond to injury. 
 
1.5 Aims of the Dissertation 
 
Male infertility is a widespread physiological disorder that effects men of 
diverse backgrounds, ages, and ethnicities. Infertility is usually described as an 
inability to properly produce a threshold level of mature sperm (>20 million/ml), 
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suggesting a problem with the normal function of spermatogenesis. The cellular 
mechanisms that disrupt spermatogenesis and result in infertility are only partly 
understood. However, there is increasing evidence that apoptotic regulation is an 
important contributor to the proper maintenance of germ cells within the 
spermatogenic process. Furthermore, the homeostasis of the Sertoli cell is thought 
to be at the heart of relative germ cell number and maturity. 
MEHP is an established Sertoli cell damaging agent and a common 
environmental toxicant. The use of MEHP allows for the analysis of how Sertoli 
cell damage induces germ cell stress and ensuing apoptosis. The approach is 
logical based on the known findings that the Sertoli cell sets the maximum 
number of germ cells to be supported in the testis. Prior research in our lab and 
others have determined that Sertoli cell damage shifts the balance from germ cell 
proliferation to death, reducing mature sperm within the testis, and potentially 
advancing lower fertility. 
We posit here that MEHP may contribute to testicular dysgenesis by up-
regulating apoptotic factors expressed in germ cells, particularly those above the 
Sertoli cell tight junctions. These are the meiotic germ cells that primarily rely on 
the support of the Sertoli cell and thus would be the most effected by a toxicant 
challenge. Significant reduction of this segment of the germ cell population 
impacts the ability of the testis to produce normal levels of mature sperm, 
potentially leading to the dysgenesis syndrome correlated with infertility. 
The aim of this dissertation is to evaluate the spermatocyte proteins 
thought to be directly involved in apoptosis following MEHP administration. The 
proposed mechanism to regulate germ cell death following MEHP exposure 
describes three important steps in the process: 1) the role of the transcription 
factor p53, 2) the expression of death receptors in targeted cells, and 3) the 
modulation of anti-apoptotic protein c-FLIP expressed in germ cells. In addition, 
the dissertation addresses the cell specificity of testicular apoptosis and novel 








2.1 Animals  
  
Approximately 28 day-old C57BL/6J mice were purchased from Jackson 
laboratories (Bar Harbor, ME). Adult male Fisher rats were purchased from 
Harlan Sprague Dawley (Indianapolis, IN). Breeding pairs of TRAIL gene 
deficient C57BL/6 mice (TRAIL-/-) were provided by Amgen Inc. (Thousand 
Oaks, CA). Breeding pairs of DR5 gene-deficient C57BL/6 mice were provided 
by Dr. Wafik El-Diery (University of Pennsylvania, Philadelphia, PA). Itchy mice 
were a gift from the laboratory of Dr. Lydia Matestic (University of South 
Carolina, Charleston, SC) and Dr. Nancy Jenkins (National Institute of Health, 
Washington, DC) Itchy mice are not gene deficient but possess a radiation-
induced pericentric inversion on chromosome 2, resulting in the loss of Itch gene 
functionality (Perry, 1998). Thus, Itchy mice are referred to as Itch protein 
deficient. p53-/- mice were provided by Dr. Lawrence Donehower (UT-MD 
Anderson, Houston, TX). The mice are described as chimeric: 75% C57BL/6, 
25% 129S/v (Donehower, 1992).  
All animals were allowed to acclimate for 1 week upon arrival at the 
University of Texas Animal Resource Center before experiments were performed. 
The mice were housed under a 12 h light cycle, constant temperature (74±2 °F) 
and at 30-70% relative humidity. The mice were given water and lab chow ad 
libitum. All procedures involving animal use were performed in accordance with 
the guidelines of the University of Texas at Austin’s Institutional Animal Care 
and Use Committee and the National Institutes of Health. 
 Note: There is a slight difference in the apoptotic response to MEHP in 
C57/BL6/J mice versus C57/129S/v strains, which are the background of the p53 
deficient mice. In the former, apoptosis and caspase-8 activation occurred most 
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prominently at 12 hours, with a slight trimming effect by 24 h, although cell death 
is still quite prevalent. The 129S/v mice exhibit a more linear death, also 
increasing significantly at 12 h but increasing through 24 h. The differences in 
sensitivity is not known at this time, although the extrinsic pathway is engaged in 
both strains and the mice express all other phenotypes associated with the MEHP 
treatments.  
 
2.2 Cell Culture Lines 
 
  The GC-1spg (CRL-2053) and GC-2spd (ts) (CRL-2096) cell lines were 
obtained from the American Type Culture Collection (Rockville, MD). The GC1 
cells used are of a spermatogonia lineage and were cultured at 37°C for at least 48 
hours prior to treatment exposures. GC-2spd(ts) (a temperature sensitive cell that 
allows for p53 nuclear localization at 32°C but not 37°C), undergo cell death by 
addition of various apoptotic stimuli. The cell line also expresses all apoptotic 
proteins examined in the present study. The GC-2 cell line was originally 
developed by Hofmann et al. as a means to study the process of germ cell 
differentiation
 
(Hofmann, 1992). The cell line was generated by transforming the 
SV40 virus’ large T antigen into preleptotene spermatocytes of six week old 
BALB/c mice and subsequently co-transfecting them with a plasmid carrying a 
p53 mutant gene (p53
Val-135
). The mutant p53 protein is fully active at 32ºC, only 
partially active at 37ºC, and completely inactive at 39ºC. The activity of the 
protein is determinant on the correct folding of p53, which is inhibited at the 
higher temperatures. Therefore, the GC-2 line affords experimentally a functional 
p53+/+ or p53 -/- germ cell model. Furthermore, this cell line is an appropriate in 
vitro model for our purposes since these cells were derived from spermatocytes, 





 II. In Vivo Methods: 
 
 2.3 MEHP administration and challenge  
 
 All MEHP treatments were administered in mice of approximately 28 days 
of age. Mice were given a single dose of MEHP (1 g/kg) by oral gavage, a 
standard dosing procedure for the investigation of MEHP-induced testicular 
injury (Giammona, 2002). Mice received MEHP in corn oil at a volume of 4 
ml/kg. Control mice received a similar volume of corn oil vehicle. Vehicle- and 
MEHP-exposed mice were killed by CO2 inhalation at the time points indicated. 
Both testes were rapidly removed and either rapidly frozen in liquid nitrogen and 
stored at -80°C or was immersion-fixed overnight in Bouin’s solution 
(Polysciences, Inc., Warrington, PA, washed in 70% ethyl alcohol-Li2CO3 
(saturated solution; Mallinkrodt, Paris, KY) and embedded in paraffin. 
 
2.4 Primary rat seminiferous tubule explants 
 
 Adult male Fisher rats were killed by CO2 inhalation and their testes were 
rapidly excised, the tunica albuginea removed, and the remaining seminiferous 
tubules placed in a petri dish of PBS at room temperature as previously described 
(Kotaga, 2004). Using the transillumination technique under a dissecting 
microscope, individual stage VIII-XII seminiferous tubules (representing the 
tubules thought to be most sensitive to MEHP) 1 mm in length were dissected 
from the surrounding interstitial tissue with fine stainless-steel forceps and placed 
in media. Stage VIII-XII segments of seminiferous tubules were chosen for the 
experiments since these stages contain spermatocyte populations known to 
undergo death receptor-mediated apoptosis
 
and also because they can be easily 
and repeatedly identified via the transillumination technique (Kangasniemi, 
1990). Tubules were added to Sertoli cell media (F-12/DMEM, 1:1) in 6-well 
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plates and incubated overnight at 32°C. Afterward, 0.5 µg/ml of hTRAIL, and/or 
100 µM of the caspase-3 inhibitor z-DEVD-FMK (EMD Biosciences, San Diego, 
CA) or TRAIL/DEVD was then added to the culture and incubated for 10 h 
before counting the number of apoptotic cells per tubule. Seminiferous tubules 
segments were then squash mounted on slides and apoptotic germ cells were 
labeled by the TUNEL method using the ApopTag kit (Intergen, Purchase, NY).  
 
2.5 In Situ Detection of mRNA in Mouse Testicular Tissues 
 
 Paraffin tissue cross sections (5 µm) were prepared from testis tissues of 
wild type mice treated with MEHP as described above. The tissues were then 
deparaffinized with Citrisolv for 15 m and subjected to a serial alcohol wash 
(100%, 90%, 70% ethanol). Single stranded oligonucleotide primers (synthesized 
by IDT Technology, Coralville, IA) were designed to interact with specific DR5 
RNA sequences. Primer sequences were: sense (5-cgt ctc tct tgg acc gac aga cat 
cta gca cga caa atg act cta-3) and antisense (3-gca gag aga acc tgg ctg tct gta gat 
cgt gct gtt tac tga gat-5). The primer set was modified with biotin addition to the 
five prime end, then applied to the tissue in a 200 pmol/mL concentration for 2 h 
and incubated at 37°C. The tissues were de-proteinized by treatment with protease 
K (20 µg/ml) prior to primer hybridization. A streptavidin-alkaline phosphotase 
conjugate was then added to the tissue for a 40 minute incubation at 37°C. 
Samples were washed twice in a detergent buffer followed by a 20 minute 
incubation in BCIP/NBT, a colorimetric substrate visualized using light 
microscopy. All reagents from Maxim Biosystems High Sensitivity In Situ Kit 
(IHD-0050) 
 
2.6 Immunohistochemical detection of proteins 
 
  Wild type male C57BL/6J mice were treated with MEHP or corn oil 
vehicle as described above. After 24 hours, testis were removed, fixed in Bouin’s 
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reagent and embedded in paraffin before being sliced at 5 µm thickness. 
Following de-parafinization and hydration, the samples were processed for 
antigen unmasking using 10 µM sodium citrate and 0.2% Triton X. After 
blocking with 10% goat serum at room temperature for 20 minutes, the p53 
protein was labeled by incubating tissues overnight at 4°C with a goat polyclonal 
primary antibody (SantaCruz, SC-1312). The primary antibody binding was 
detected using a donkey anti-goat secondary antibody conjugated with biotin. A 
horseradish peroxidase kit (Vector Labs, # PK-6102) was used to conjugate biotin 
with DAB for chemiluminescent detection.  
 
2.7 Morphological evaluation of testicular tissue 
 
  Sections (5 µm) of paraffin embedded tissues were evaluated for 
morphological changes via standard methods using periodic acid-Schiffs-
Hematoxylin (PAS/H). Tissues were imaged using a Nikon E800 microscope 
equipped with a digital camera and captured using MetaMorph software 
(Downingtown, PA). 
 
2.8 Immunofluoresent detection of testicular antigens 
 
      Sections (5 µm) of paraffin embedded tissues were also exposed to 
fluorescent antibody treatment. Following removal of paraffin with citrosolv (15 
min), the tissues are heated for 20 min to “unmask” the protein antigens of 
interest. The tissues were then subjected to .3% triton X before three washes in 
PBS. Goat serum was diluted 1:10 in PBS and used to block the tissue sections for 
thirty minutes. A rabbit polyclonal anti-Itch antibody (Abgent, # AP2127a) is 
applied and allowed to react overnight at 4° C. After three washes with PBS, 
Alexafluor 488 (1:10,000) is applied for thirty minutes. The slides were then 
evaluated using the Metamorph software on the Nikon E800 microscope. 
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III. In Vitro Methods 
 
2.9 In Vitro culture treatments 
 
   GC-1 or GC-2 cells that had been in culture for 48 h (grown at either 
temperature) were exposed to various treatments including anti-Fas agonistic 
antibody Jo2 (E-Biosciences), recombinant soluble mouse TRAIL (mTRAIL, 
cat. #SE-722, Biomol, Plymouth Meeting, PA), recombinant human TRAIL 
(hTRAIL, provided as a kind gift of Dr. SB Bratton, The University of Texas at 
Austin), functional grade purified anti-mouse DR5 antibody (Clone MD5-1, cat. 
#16-5883, eBioscience, San Diego, CA), z-VAD-fmk-FMK (cat. #27610, 
Calbiochem, La Jolla, CA), cyclohexamide (cat #GR-310, Biomol, Plymouth 
Meeting PA). Pretreatment of cells with pifihthrine-∝ (AG Scientific, P1177), 
cyclohexamide (1 µg/ml), pan-caspase inhibitor z-VAD-fmk-FMK (10 µM), or 
with anti-DR5 antibody (0.5 µg/ml) were added 30 minutes prior to TRAIL 
addition. Evaluation of cell morphology was performed using a Nikon TMS-100 
phase contrast microscope and images were captured using a Nikon CoolSnap 




  GC-2-spg(ts) cells were cultured in 6-well plates (1 X 106 cells/well 
plated) as previously described. Briefly, the cells were cultured for 24 hours at 
37° C post split and cultured for an additional 24 hours at 32° C, thus activating 
the p53 gene. At 48 hours, select wells were treated with 5 µg/mL Fas-activating 
antibody (JO2) for a period of 3 and 6 hours. For collection, cells were lysed and 
removed from the wells using RIPA lysis buffer made in the lab (1% IPEGAL, 
150 mM NaCl, .5 % sodium deoxycholate, .1% SDS, 50 mM Tris, 8.0 pH) with 
1 mM PMSF protease inhibitor added. Lysates were precleared with 50 µl (50 % 
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slurry) of Protein G sepharose (Amersham) in 500 µl lysis buffer for 1 hour. The 
supernatent was retained following clearing,  and 2.5 ug of rat monoclonal anti-
cFLIP antibody was added to the supernatent for one hour at 4 C. A 
supplementary 50 µl of sepharose was added to the supernatent and incubated for 
two additional hours at 4º C. The captured antibody-protein G complexes were 
then washed three times with lysis buffer and once with PBS. After the addition 
of SDS running buffer, Protein G was removed from the protein by boiling for 5 
minutes, at which point the complexes were loaded into a 12% polyacrylamide 
gel and separated by electrophoresis. The protein was transferred to a 
nitrocellulose membrane and subsequently probed for with the C-Flip (Dave-2) 
rat monoclonal (AbCam, ab16078) antibody and Ubiquitin rabbit polyclonal 
(Stressgen, SPA-200) antibodies. 
 
 2.11 Flow cytometric analysis of apoptosis 
 
   The annexin-V / propidium Iodide (PI) assay was used to identify 
apoptotic cells via annexin-V’s ability to bind to externalized phosphotidylserine 
molecules (van Engeland, 1998). PI is expelled from live and early-apoptotic 
cells that maintain their cell membrane integrity, while being retained by dead 
cells or cells undergoing secondary necrosis/late apoptosis. Cell death is 
qualified based on their “apoptotic” characteristics (Annexin-V positive stain) 
using a flow cytometer. After the indicated treatment(s), cells were collected by 
brief trypsinization (using a 0.25% solution of trypsin with 0.03% EDTA) 
followed by centrifugation at 400 x g for 6 min. They were re-suspended in fresh 
media for about 30 min to neutralize the effects of trypsin. The cells were then 
pelleted by centrifugation at 400 x g and the cell pellets were washed and 
resuspended in binding buffer as per the manufacturer’s instructions (Annexin-V 
FITC apoptosis kit, cat. #556570, BD Biosciences Pharmingen, San Diego, CA). 




cells/ sample were incubated with 5 µL of annexin-V 
conjugated with fluorescein isothiocyanate (FITC) for 5-10 min. The cells were 
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then incubated with 10 µL of PI for 2-5 min. Flow cytometric analysis of these 
cells was carried out on a Coulter Epics XL-MCL flow cytometer (Beckman 
Coulter, Inc., Fullerton, CA). 
 
2.12 Flow cytometric analysis of DR5 receptor expression on GC-2 membranes 
 
 The DR5-labeling procedures were performed according to the method of 
Jin et al. with modifications (Jin, 2004). GC-1 and GC-2 cells (1 x 10
6
 cells) 
were grown in 6 well plates at either 37 or 32°C. At designated time points, the 
cells were rinsed with phosphate buffered saline (PBS) and subsequently 
detached from culture plates using 0.05% trypsin solution containing EDTA. 
Cells were re-suspended in DMEM and were centrifuged at 4 ºC at 400 x g for 5 
min followed by a wash with PBS supplemented with 2 % fetal bovine serum 
(FBS). The cell pellets were then re-suspended in 50 µl of PBS (with 2 % FBS) 
containing 0.02 µg/µl of the primary antibody against DR5 (Cat. #210-743, 
Alexis, CA) or the isotype control (hamster IgG, Pharmingen). Cells were 
incubated with the primary antibody on ice for 1 h followed by a wash with 1 ml 
2% FBS in PBS. The cells were then incubated with a secondary antibody (goat 
anti-hamster IgG) conjugated to Alexa fluor

 488 (A-21110, Molecular Probes, 
Eugene, OR, USA) at 20 µg/ml for 1 h on ice in the dark. After washing the cells 
with 2% FBS in PBS, cells were re-suspended in PBS. Flow cytometric analysis 
of these cells was then carried out on the Coulter Epics XL-MCL flow 
cytometer.  
 
2.13 Western blot analysis 
 
 All proteins of interest were evaluated in GC-2 cell lines for total cellular 
protein levels via western blot analysis. Western blots were performed using the 
primary antibodies against the relevant protein in the appropriate dilution 
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(usually .5 ug/ml). Horseradish peroxidase-conjugated secondary antibodies 
(SantaCruz Biotechnology) were used to detect primary antibodies. Signals were 
detected by the use of an ECL kit (Amersham Pharmacia Biosciences, 
Piscataway, NJ). Images were collected by a Kodak DC-290 digital camera and 
densitometric analysis was performed using Kodak 1D Image Analysis Software 
(Kodak Digital Sciences, Rochester, NY). Each protein was analyzed in a 
minimum of three GC-2 sample sets, and representative blots have been 
presented. Equal loading (20 µg) was verified by comparing expression levels of 
b-actin. 
 
2.14 Confocal detection of DR5 on the cell membrane   
 
 GC-2 cells were grown at 37°C, trypsinized, and inoculated into four 
chambered slide plates (Lab Tek II, 125652) at approximately 1.0X10
5  
cells per 
well. A portion of the cells were grown at 24 h at 37°C, and then transferred to 
32°C for 24 h to activate p53. P53 negative cells were kept at 37°C for 48 hours. 
Both sets of cells were then treated with 0.5 µg/ml of MD5-1 for 30 mins, 
followed by treatment with 0.5 µg/ml of mouse TRAIL. Both sets of cells were 
collected at 2 h time points. Cells were then fixed in ice-cold 1:1 
methanol/acetone for 10 minutes and air-dried. Following three washes with PBS 
and a 20 min blocking step in a 10% goat serum, the cells were incubated 
overnight in DR5 (Abcam, # ab8416) primary antibody diluted to a 1:100 ratio. 
The cells were then washed thrice with PBS and goat anti-rabbit Alexa Fluor 488  
(Alexis) secondary antibody was added in a 1:1000 ratio. The slides were then 
mounted using VectorShield mount (VectorLabs, # H-1300) containing PI to 
stain the nucleus. Fluorescing cells were evaluated using the Leica SP2 AOBS 






2.15 Use of siRNA to knockdown Itch protein 
 
 In 12-well plates, approximately 7 x 104  GC-2 cells were plated per each 
well. Mixed with the cells was a cocktail of serum-free OPTI-MEM (Gibco), 30 
nM of Itch siRNA, and the Amine transfection agent. The cocktail was activated 
by initially combining the transfection agent and OPTI-MEM at room 
temperature for 10 minutes. This mixture was then combined with appropriately 
diluted siRNA (30 nM final concentration) for an additional 10 minutes at room 
temperature. Gently the cocktail and GC-2 cells were combined and allowed 
incubate for 24 hrs at 37° C. One plate was then placed at 32° C for an additional 
24 hrs. Media was replaced at the 24 hour time point and protein knockdown was 
evaluated by western blotting 48 hours after initial transfection. The Itch siRNA 
was designed and synthesized by Ambion (Austin, TX) and the Easy Silencing 
kit (Ambion # 1640) was used to complete the transfection. 
 
2.16 Protein detection of c-FLIP using silver staining 
 
 Following immunoprecipitation (described above) of FLIP, the pull-down 
products were loaded into a 10% Bis-Tris acrylamide gel and run for 1 hr at 130 
milliamps. The gel was then transfered from the  electrophoresis apparatus into a 
clean plastic dish for 20 m incubation in a fixing buffer (40% methanol, 5% 
acetic acid, 55% water) at a gentle rotation. Sensitizing solution is added 
between two washes of ethanol (30%) for 10 m a apiece, then water for 10 m. A 
silver ion staining solution is then added for 15 m, followed by a brief rinse, and 
the introduction of developing solution for approximately 10 m. Once the silver 
stain is clearly observed, a stop buffer is added to prevent overexposure. All 
buffers and stains (except for fixative and ethanol washes) were found in the 
Silverquest Silver Stain kit (Invitrogen, # LC-6070). Photos were taken using the 
Kodak 1D Image Analysis Software (Kodak Digital Sciences, Rochester, NY). 
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2.17 Statistical methods 
 
   Significance between groups (p < 0.05) was determined by using the 
parametric single factor analysis of variance (ANOVA) test, followed with the 
Fisher PLDS post-hoc comparison test using Statview software (SAS Institute 






































p53 activity plays a role in the apoptosis of germ cells 
  
 3.1 Introduction and Rationale 
 
 The involvement of the p53 protein in the apoptotic pathway is well 
documented. This transcription factor has been implicated in cell cycle arrest, 
apoptosis following DNA damaging agents such as ionizing radiation and reactive 
oxygen species, as well as in a variety of non-genotoxic stressors including 
hypoxia (reviewed in Lavin and Guerin, 2006). In addition, p53 can mediate cell 
death by regulating proteins of both the intrinsic and extrinsic apoptotic pathways.  
 The activity of p53 in germ cells is known to be indispensable in the 
proper regulation of cell cycle progression during mitosis and meiosis, two 
processes key to spermatogenesis, and appears  to be especially important in 
spermatocytes (Almon, 1993), (Rotter, 1993). p53 deficient mice are fertile but 
exhibit defects in spermatogenesis, including increased levels of germ cell 
degeneration (Rotter, 1993).  However, the function of p53 in toxicant induced 
apoptosis is unknown. Testicular apoptosis can be triggered under a variety of 
conditions, resulting in changes to germ cell or Sertoli cell homeostasis. Heat, 
radiation, and torsion are examples of stress models that directly effect the germ 
cell, promoting death by damaging DNA or reducing oxygen to the tissues 
(Embree-Ku, 2002), (Lysiak, 2000).  
 MEHP, however, is known to specifically target and damage Sertoli cells. 
Because of its established role in providing support for up to thirty germ cells at a 
given time, any change in Sertoli cell homeostasis potentially impacts germ cell 
numbers as a secondary event. Increased membrane expression of death ligands 
TRAIL and FasL is one possible consequence of Sertoli cell damage 
(Boekelheide, 1998). Withdrawal of growth factors or nutrients from the germ 
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cell may also facilitate the early stages of its apoptosis. An important question not 
currently understood is how the germ cell senses and responds to these stresses.  
 The p53 protein has been implicated as a factor that responds to testicular 
stress (Yin, 1997). The protein exerts a measure of regulatory control over the 
expression of intrinsic pro-apoptotic proteins Bax, Noxa, and Puma. However, 
there is limited  data reporting initiation of mitochondrial apoptosis in germ cells 
other than after DNA damage (Erster, 2004). Genotoxic stress may also be 
transcription-independent, with p53 localizing to the mitochondria in a 
mechanism that blocks bcl-2 and allows for the release of cytochrome c (Erster, 
2004). On the other hand, p53 transcriptional targets associated with the extrinsic 
pathway may be increased after toxicant-induced stress in germ cells 
(Chandrasekaran, 2005), (Giammona, 2002). An indirect link to p53 
transcriptional activity was previously established when Lee et al. determined that 
the Sertoli cell toxicant MEHP increases Fas expression in the testis (Lee, 1997). 
Management of many p53-dependent apoptotic proteins is thought to be achieved 
largely at the mRNA level. The genes for Fas and DR5 both contain a p53 
response element, thus placing them under the transcriptional control of the 
protein (Owen-Schaub, 1995), (Wu, 1997). Furthermore, the functional activity of 
p53 is correlated with the expression of death receptors in well established models 
as heat stress and ionizing radiation in the testis (Boekelheide, 2005), (Miura, 
2002).  
 Controlled expression of pro-apoptotic proteins preserves a balance 
between death and survival. New evidence suggests that cells commonly removed 
in the “first wave” of apoptosis in developing testis may be driven by Fas and 
other proteins within the extrinsic pathway (Lizama, 2006). Thus, death receptor 
expression could be essential for the routine development of normal 
spermatogenesis. In contrast, its misregulation is commonly associated with 
testicular disease. For instance, cryptorchidism, a developmental defect of the 
testis and a component of testicular digenesis syndrome, is strongly correlated 
with p53 and Fas over-expression (Yin, 2002). 
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 Cellular stressors in the testis may lead to the loss of germ cells and 
impediment of spermatogenesis. The focus of this chapter evaluates the 
possibility that MEHP mediated Sertoli cell damage is influenced by p53 present 
in germ cells, leading to its increased activity and transactivation of pro-apoptotic 
proteins, specifically in spermatocytes. The spermatocyte subtype represents the 
main population of germ cells residing in the adluminal space and as a result is 
the most likely cell type to be effected by MEHP treatments. The p53 protein has 
been suggested as a “guardian” of germ cell integrity, potentially reducing 
damaged or degenerate cells that may inhibit spermatogenesis (Yin, 2002). The 
hypothesis here assesses whether p53 transcriptional activity is an important 
physiological response in germ cells that have been treated with MEHP and if its 
a major determinant of their sensitivity to apoptosis. 
 Although MEHP is an established Sertoli cell damaging agent, its exact 
mechanism of inducing germ cell apoptosis is speculative. Here we present 
evidence that the p53 protein is stabilized in testicular germ cells following 
MEHP treatments and that this stabilization results in the increased production of 
death receptors Fas and DR5. This association between p53 and death receptor 
expression can be observed both in vivo and in vitro and correlates with increased 
incidence of apoptosis, specifically in the spermatocyte. In p53-/- mice or cultured 
germ cells grown at p53 non-permissive temperatures, the induction of death 
receptors is reduced and overall less caspase-8 activation is seen. The data 
indicates that p53 response is an important factor in producing an extrinsic 









 3.2 Results 
 
A. MEHP induces apoptosis in the seminiferous tubules of C57/B6/J mice 
 
 Exposure of C57/BL6/J mice to a standard MEHP treatment by route of 
oral gavage induces cell death in the seminiferous tubule (Fig 3.1). A comparison 
between control and MEHP treated mice shows that the tubules of the latter reveal 
higher levels of germ cell apoptosis, retraction of the Sertoli cell cytoplasm, 
increased vacuolization, larger lumens, and fewer overall germ cell numbers (see 
Fig. 3.1 legend). This data is consistent with earlier findings that MEHP 
treatments can lead to Sertoli cell damage and potential for impaired 
spermatogenesis, testicular dysgensis syndrome, or both. In situ DAB staining 
(TUNEL) shows that cell death increases in the seminiferous tubules when treated 
with MEHP and that the apoptosis was concentrated chiefly in pachytene 
spermatocyte and possibly early round spermatid populations. 
 
B. p53 protein levels are stabilized or increased in spermatocytes after MEHP 
exposure 
 
 Evaluation of p53 protein expression by immunohistochemistry in 
testicular tissue sections reveals a low level of p53 distributed throughout the 
spermatocyte population of the seminiferous tubules of non-treated animals (Fig. 
3.2A) In the testis from MEHP-treated mice, p53 levels were found to be 
considerably elevated specifically in spermatocyte populations by 24 h (Fig. 
3.2A). Spermatocytes are among the most sensitive populations of germ cells to 
undergo MEHP-mediated apoptosis, as observed using TUNEL in situ 
hybridization (Fig. 3.1). Morphological changes are consistent with the retraction 
of the Sertoli cell membrane following MEHP treatment and p53 protein is 
localized to a ring of spermatocytes along the basement membrane. Thus, p53 
expression and apoptosis appear to be correlated in spermatocytes. 
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 To determine if p53 is stabilized through post-translational modification, 
MEHP-treated testicular samples were immunoblotted and probed for changes in 
phosphoylation status (Fig 3.2B). Phospho-serine-18 (mouse specific), known to 
disrupt the association of p53 and its inhibitor, MDM-2, were not observed with 
or without MEHP. Phospho-serine-18 was detected in UV-treated (30 m, 254 nm) 
GC2 cells used as a control. However, phosphorylation of p53-serine-392, known 
to increase p53 nuclear localization and apoptosis, was detected and increased 
following MEHP in wild type mice.  
  
C. Increases in p53 transcriptional activity correlate with higher death 
receptor expression in vivo and in vitro 
 
 Western blot analysis of wild type testis showed an increase in  Fas death 
receptor expression concomitant with longer exposure to MEHP. Fas levels in p53 
deficient mice did not significantly increase, although initial concentrations are 
detectible in the tissue lysate (Fig. 3.3 A). GC-2 cells showed differences in the 
amount of the death receptors expressed between cells that express large amounts 
of functional p53 (32° C) or low amounts (37°C) (Fig. 3.3B, for both 32° & 
37°C). Both Fas and DR5 total cell protein is elevated at the permissive 
temperature (32° C)   
 Immunoblotting also showed the abundant expression of the p53 
dependent p21 protein only in GC-2 cells maintained at the permissive 
temperature, indicating the ability of p53 to enter the nucleus and up-regulate its 
target genes (Fig. 3.3B, p21 row). Previous observations showed the 
phosphorylation of p53 on serine-392 is associated with its stabilization in the 
nucleus and was shown to increase after MEHP exposure in vivo (Fig. 3.2B). The 
data indicated that p53 nuclear translocation is potentially important for its 
cytotoxicity. In keeping with this hypothesis, the expression of p53 sensitized 
GC2 cells to apoptosis. Cells grown at the p53 permissive temperature underwent 
greater apoptosis (19.5%) than those at the non-permissive (5.2%) as determined 
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by annexin-PI flow cytometry (Fig. 3.4A). Addition of a Fas cross-linking 
antibody (Jo2) induced further death at both temperatures, but more meaningfully 
when p53 is expressed at a higher rate (32.3%).  
 The p53 blocking compound Pfithrin-∝ (PFT-∝, 50 µgs) was used to 
decrease the ability of p53 to enter the nucleus and test if GC2 cells were 
protected from cell death. Western blotting showed enhanced Fas expression at 
the p53 permissive temperature with no treatment. However, pre-treatments with 
PFT-∝ reduced Fas protein almost to the level detected in p53 non-permissive 
cells, consistent with a reduction in p53-mediated transcription (Fig. 3.4B). The 
results of annexin-PI flow cytometry shows that in PFT-∝ pre-treated, samples 
show decreases in Fas that may explain protection of GC2 cells from apoptosis at 
the p53 permissive temperature (Fig. 3.4C). This data suggests a correlation 
between p53, the increased expression of death receptors, and apoptosis in 
spermatocyte germ cells. 
 
D. MEHP promotes apoptosis through the extrinsic pathway and is p53 
dependent 
   
 Treatment of wild type or p53 deficient (-/-) mice with MEHP activates 
caspase-8, an integral protein in the extrinsic pathway. After treatment of both 
wild type and p53-/- mice with 6, 12, or 24 h with MEHP, changes in protein 
levels were determined by western blotting. Processing of caspase-8 was shown to 
increase as early as 12 h and continue through 24 h. (Fig. 3.5A) The active 18 kD 
sub-unit was detected in the lysates of all wild type animals, but was significantly 
increased following MEHP in the 12 and 24 h time point. A lack of activation was 
shown in the cells of p53-/- mice, indicating that without the transcription factor, 
very little caspase-8 is activated following MEHP. The full length procaspase-8 
band (56 kD) the major product in these mice, although the primary processing 























Fig.3.1 MEHP Induces Testicular Apoptosis in C57/B6/J Mice. Exposures of MEHP by 
oral gavage induces apoptosis in the testis of wild type mice. MEHP causes various 
morphological disturbances to the seminiferous tubules, including reduced Sertoli cell 
cytoplasm, increased lumens, and vacuolization in addition to increased incidence of 
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  Fig.3.2 MEHP Stabilizes p53 Expression in Spermatocytes of C57/B6/J Mice. (A) 
Immunohistochemistry of mouse testicular tissue following a MEHP treatment. 
Control mice show general p53 staining distributed among spermatocyte 
populations in the tubule. Animals treated with MEHP for 24 h show robust p53 
staining (arrows) specifically in spermatocytes. (B) p53 is phosphorylated on 
serine-18 (mouse specific) only in UV-treated GC2 cells and not in vivo. Serine-
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Fig. 3.3 Expression of death receptors is p53 dependent in vivo and in vitro. (A) 
Wild type mice treated with MEHP show increases in Fas death receptors, but 
p53-/- mice are protected. (B) Spermatocyte-like GC2 cells also express death 
receptors Fas and DR5 in a p53 dependent manner. The expression of increased 
p21 also indicates p53 translocation into the nucleus.  
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Fig. 3.4 p53 activity correlates with Fas expression and increased apoptosis in 
GC2 cells. (A) Cell death is higher in GC2 cells grown at p53 permissive tissues 
than at non-permissive temperatures and is increased by Fas-linker Jo2. (B) 
Pifithrine-α pre-treatments reduces Fas expression in GC2 cells when p53 levels 
are high, suggesting transcriptional regulation. (C) Reduced Fas expression 














































37º C       32º C 
32º C 
37º C   
 
 66 
E. MEHP treatment increases DR5 mRNA in spermatocytes: 
 
 To test the cell specific changes in DR5 mRNA after MEHP, in situ 
hybridization was performed. DR5 mRNA in testis from untreated mice could be 
detected in spermatocytes (Fig. 3.6A). However, DR5 mRNA levels are increased 
in the testis as early as 3 h (Fig. 3.6B) following MEHP treatment and were 
maintained through the latest time point collected (24 h, panel D). The expression 
of DR5 in germ cells from treated mice was most prominent in early 
spermatocytes that became located along the basement membrane of the 
seminiferous tubule due to the retraction of the Sertoli cell membrane. MEHP is 
known to induce alterations in Sertoli cell structure in rodents such as retraction 
of the Sertoli cell plasma membrane, evident here in all treated tubules, especially 
at 24 h. (Fig. 3.6D). PAS/H staining and microscopy identified the stage 
(maturity) of effected germ cells. High levels acrosomal staining and hemotoxylin 
detected the condensed chromatin pattern seen in spermatocytes. Further analysis  
confirmed that the majority of the cells as pachytene spermatocytes most often 


































Fig. 3.5 Caspase-8 is activated in vivo following MEHP exposure. In wild type 
mice, caspase-8 processed from (p43) and active fragment (p18) is detected at 
higher levels following toxicant treatment. Mice deficient in p53 did not express 
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Fig. 3.6 MEHP treatment of C57/BL/6 mice increases DR5 mRNA expression in 
germ cells. Localization of DR5 in germ cell subtypes determined via in situ 
hybridization of  testis from vehicle- or MEHP-treated of wild type mice. 
Representative testis sections from mice exposed to vehicle (A), or MEHP for 3 h 
(B), 12 h (C), or 24 h (D) are shown. Hybridization of primer RNA occurs 
generally in the spermatocyte population of germ cells in the testis of vehicle-
treated mice (A). Significant increases in DR5 expression are seen in testis by 3 h 
following MEHP treatment in early spermatocytes. Morphological assessment of 
the tissue was achieved using PAS & H staining (E and F). Bar equal to 100 µm.  
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 3.3 Discussion 
  
 Previous investigations have evaluated the functional role of MEHP in the 
induction of germ cell apoptosis (Oishi, 1980), (Boekelheide, 1989). There is 
substantial evidence suggesting that MEHP and other phthalates actively target 
and promote damage to the Sertoli cell, which directly controls the number germ 
cells that can be maintained under physiological conditions (Richburg, 1996),  
(Richburg, 2002). Germ cells not sufficiently supported are thought to be 
removed from the testis through the process of apoptosis. Thus, upon damage, the 
Sertoli cell expresses the death ligands FasL and TRAIL, which interact with their 
cognate receptors found on the apoptotic germ cell membranes (Grataroli, 2002), 
(Giammona, 2002). Germ cell numbers will decline as a function of Sertoli cell 
health and ultimately result in decreased incidence of spermatogenesis and 
increased dysgenesis/infertility. While it has been reported that p53 and death 
receptors are involved in germ cells targeted for apoptosis after MEHP, the 
mechanism by which they do so remains unsolved.  
Chandrasekaran and Richburg have shown that the sensitivity of germ 
cells to undergo apoptosis after toxicant-induced testicular injury may be 
dependent on p53 status (Chandrasekaran, 2005). The linkage between p53 
activation in the cell and its sensitivity to death receptor activation was indicated 
when a lower incidence of basal apoptosis was observed in p53 null (-/-) mice 
than wild type controls. In addition, mice deficient in the expression of functional 
p53 showed less incidence of cell death after treatment with the prototypical 
Sertoli cell toxicant MEHP. The reduced sensitivity to apoptosis was correlative 
with lower activation of the death receptor DR5, as western blot analysis 
indicated that the levels of this protein expression in testis cell membrane 
fractions from MEHP-exposed p53-/- mice were lower compared to those of wild-
type mice. Both DR5 and Fas were found to be substantially elevated and 
localized in germ cell membranes after MEHP treatments. The authors suggested 
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that p53 may act to facilitate movement of death receptors from the cytosol to the 
membrane in a transport capability.  
 Further investigation in this study has shown that MEHP may in fact act  
to increase or stabilize p53 protein following exposure to the toxicant. 
Immunohistochemistry of toxicant treated mouse tissue display higher 
concentrations of p53 in spermatocytes, the germ cell found to be most sensitive 
to apoptosis (Fig 3.2A). Whether the staining is cytoplasmic or nuclear is 
unknown. However, in mouse testis, the p53 protein is known to reside in close 
proximity to the nuclear envelope, for rapid transit into the nucleus and 
subsequent transcription of apoptotic factors upon stress. (Yin, 1997)  
Morphological analysis of the tissues suggested that the germ cells were 
pachytene spermatocytes from stages seven or eight. These are the same subtypes 
most often undergoing apoptosis after MEHP (Fig 3.1). Spermatocytes may be 
particularly sensitive to toxicants due to its location in the adluminal compartment 
and because it is the site of the synapse and genetic recombination. (Odorisio, 
1998)  
 P53 is known to be stabilized through the post-translational 
phosphorylation of one or more amino acid (usually serine) sites on the protein. 
Analysis of different potentially phosphorylated serine residues show that MEHP 
does not induce modification of serine-18 (mouse specific) (Fig. 3.2B). This 
modification (along with serine-20 in humans) are known to interfere with the 
binding of MDM2, the primary regulator of cellular p53 levels (Unger, 1999). 
However, phosphoserine-392 was present constitutively and increased with 
administration of the toxicant. Modification of this residue is associated with 
higher p53 stability, and the induction of apoptosis (Sluss, 2004), (Kim, 2004). 
Phosphorylation of serine-392 possibly aids in the tetramerizaion of p53, thought 
to be a requirement for proper DNA binding  and gene transactivation (Sakaguchi, 
1997). Interestingly, phosphorylated serine-392 has been shown to interfere with 
the ability of p53 to leave the nucleus once modified. The result supports the 
possibility that p53 protein is imported to the nucleus, where it is stabilized by the 
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lack of interaction with the MDM2 regulator. In addition, increased DNA binding 
could lead to transcription of apoptotic gene targets. 
 The p53 protein is known to promote apoptosis in tumor cells and is 
thought to at least partially control Fas and DR5 transcription (Wu, 1999),  
(Munsch, 2000). However, a lack of consensus is displayed in the literature in 
concern to whether or not p53 is important in driving death receptor system in 
germ cell apoptosis. The connection between p53 expression and death receptors 
has been previously explored in our lab using p53 deficient mice 
(Chandrasekaran, 2005). While MEHP-treated mice show a linear and potent 
increase in Fas protein as determined in a 24 h time course, Fas expression in p53-
/- mice is nearly flat and does not increase significantly (Fig. 3.3A & B). The 
presence of the death receptor in p53 -/- mice shows that it is not totally 
dependent on p53 transcription. However, p53 must be active for Fas protein 
levels to increase after MEHP and to induce apoptosis. Therefore, p53 may be 
important for the regulation of Fas as well as influencing its  expression. Bennett 
et al. described a system by which p53 helped traffic death receptors from the 
golgi for placement on the plasma membrane (Bennett, 1998). 
 To fully elucidate the pathways involved, we initiated the use of the 
transformed, spermatocyte-like cell line GC2. GC2 cells are useful for several 
reasons. Firstly, the cells express all of the proteins associated with extrinsic 
apoptosis, including death receptors. GC2 cells are derived from a spermatocyte 
lineage, which is the germ cell sub-type most commonly sensitive to apoptosis 
post-MEHP exposure. In addition, the cell line contains a temperature sensitive 
mutation that results in the expression of properly folded p53 protein at the 
permissive temperature (32° C) and less so at the non-permissive temperature 
(37° C). By taking advantage of this mutational “toggle,” we could create an in 
vitro system that modeled  p53+/+ and p53-/-germ cells.  
 The GC2 cells were first used to establish whether p53 expression was 
correlative with increased apoptosis. Because MEHP is know to primarily effect 
the Sertoli cell, and has no effect when directly applied to cultured cells, the 
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agonistic antibody Jo2  (anti-CD117) was used to mimic the contribution of the 
death receptor system. Jo2 acts to link Fas receptors together in a manner that 
simulates in vivo associations after triggering by FasL. In doing so, “clusters” of  
receptor/ligand multimers can be linked together, theoretically increasing the 
chances of robust apoptosis. 
 By transferring the GC2 cells from 37° C to 32° C for 24 hours, we sought 
to potentially model in cell culture the same stimulatory effect of MEHP on p53 
protein levels seen in mouse tissues. The increased expression of p53 at the 
permissive temperature led to a robust and continuous apoptosis compared to that 
of the non-permissive temperature, supporting previous data obtained in the lab 
(Fig. 3.3A). The experiment also supports the hypothesis that a sharp increase in 
p53 activity results in germ cell apoptosis. The effect is amplified by the addition 
of Jo2 and suggests that the death receptors  are an integral part in promoting 
apoptosis in spermatocytes.    
 To determine if death receptor expression contributed to apoptosis 
following p53 activation, western blots were performed from GC2 lysates at both 
temperatures. Analysis of the results showed considerable increases in the protein 
levels of both DR5 and Fas at the p53 expressing temperature compared to the 
non-expressing temperature. (Fig. 3.3B) As seen in vivo, Fas is present at a low 
basal level, and DR5 shows a similar profile. Both proteins are amplified at the 
permissive temperature, supporting the proposition that death receptors are 
activated upon p53 activation in spermatocytes and lead to the extrinsic apoptotic 
mechanism.  
 To further investigate the link between p53 and death receptors, GC2 cells 
were treated with Jo2 anti-Fas agonistic antibody for 6 hours. The cells displayed 
the most robust cell death coincident with p53 activity. (Fig. 3.4A) Pre-treatments 
of GC2 cells with nuclear pore inhibitor Pifithrin-∝, which blocks p53 entrance 
into the nucleus, reduced the level of cell death observed at the permissive 
temperature (Fig. 3.4B). The decrease in cell death is coincident with reduction of 
Fas receptors in the same samples. GC2 cells pretreated with Pifithrin-∝ were 
 73 
able to decrease Fas levels at the permissive temperature. Thus, the ability of p53 
to transactivate Fas is positively associated with germ cell death (Fig. 3.4C). The 
results are interesting in light of the up-regulation of phosphoserine-392 levels 
observed in mice, which increases p53 nuclear activity (Fig. 3.2B).  
 Activation of caspase-8 increases in response to MEHP treatments in vivo 
(Fig. 3.5A). The data correlates with the very high levels of Fas detected at 12 
hours post MEHP and continue through 24 hours in wild type mice (Fig. 3.3A). 
The increase in Fas and activated caspase-8 suggests that both of the proteins and 
the extrinsic apoptotic program are a requirement for efficient apoptotic triggering 
in germ cells after toxicant treatment. 
 In summary, p53 appears to be stabilized through phosphorylation in 
response to MEHP treatments and subsequently exerts an influence over death 
receptor expression in the testis in vivo and in vitro. Increased death receptors lead 
to the cleavage and activation of caspase-8, an initiator of the extrinsic pathway of 
apoptosis. Low constitutive levels of Fas and DR5 can be detected prior to 
MEHP. However, with the stabilization of the p53, Fas protein is increased in 
vivo. The death receptors increases seen in vitro are probably under the 
transcriptional influence of p53, which is known to localize to the nucleus in GC2 
cells at the permissive temperature (Chandrasekaran, 2005). DR5 mRNA is also 
up-regulated by MEHP and expressed in spermatocytes. 
 Previously the Richburg lab examined the protection of gld and lpr mice 
against apoptosis triggered by MEHP. The mice have mutations in the FasL gene 
and Fas receptor gene respectively. Removal of either the receptor or ligand 
provided reduced sensitivity to apoptosis. Nevertheless, total protection to 
MEHP-mediated apoptosis was not observed, leading to the hypothesis that 
another apoptotic factor was alternately expressed. Furthermore, the experimental 
results also showed a statistically relevant increase in DR5 proteins, although the 
mechanism of the protein’s increase was unknown. In situ experiments completed 
here show that mRNA levels increase in mice treated with MEHP (Fig. 3.6A-D). 
Testicular mRNA was elevated by three hours and remained at robust levels 
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through 24 hours. Western blotting shows that Fas and DR5 also increases over 
the same general time interval (Fig. 3.3A). DR5, like Fas, is known to promote 
apoptosis through the DISC which can explain the induction of caspase-8 
activation.  
 The question of why both death receptors would be heavily expressed in 
the same tissue is a source of continued research. In fact, the TRAIL/DR5 system 
is rarely engaged in normal physiological cells and preferably induces cell death 
in tumor cells. However, a hint may lie within the particular sensitivity of 
spermatocytes to apoptosis. These cells represent the meiotic component of 
spermatogenesis and are known to be susceptible to wide range of toxicants, 
especially those that induce DNA damage and possible cell cycle arrest. DR5 is 
known to be under the control of p53, either by direct transcription or  an indirect 
regulation, and DR5 levels are increased in the same spermatocytes that exhibit 
p53 stabilization. Because increases in DR5 mRNA in response to MEHP is a 
novel and intriguing observation, we wanted to look more closely at the protein 
and its expression in the germ cell. In doing so, the importance of the 
TRAIL/DR5 system in physiological cells may be revealed, as explored in the 
next chapter. 




















Sensitivity of Spermatocytes to TRAIL/DR5 Mediated Apoptosis 
 
 4.1 Introduction and Rationale 
 
 The TRAIL/DR5 tandem is a cell death inducing system analogous to 
FasL/Fas. Both represent a ligand/receptor interaction that triggers activation of 
the DISC proteins and apoptosis mediated through the caspases of the extrinsic 
pathway. However, TRAIL/DR5 possesses an intriguing specificity for 
tumorigenic cells and under most circumstances is inactive in physiologically 
healthy cells (Meurette, 2006), (Kim, 2000). For this reason, controlled 
engagement of the system has been proposed for use as a cancer 
chemotherapeutic strategy (Ichikawa, 2001), (Kelley, 2004), (Guo, 2005). As 
observed in the previous section, DR5 mRNA and its protein product is expressed 
at high levels in germ cells following MEHP and is correlative with apoptosis. An 
understanding of the mechanisms that confer this sensitivity of germ cells to 
TRAIL-mediated apoptosis, which is usually limited to the killing of tumor cells 
and not the inappropriate apoptosis of ‘normal’ cells, would be useful when 
investigating therapeutic applications. However, the instigation of TRAIL/DR5 
may damage tissues not undergoing tumor growth. This may be particularly 
important for cells with high proliferation rates such as the testis, ovary, skin and 
bone marrow. 
The functional importance of the death receptor signaling system in 
controlling testicular germ cell apoptosis has been revealed previously using a 
toxicant model system (Giammona, 2002). Exposure of rodents to mono-(2-
ethylhexyl) phthalate (MEHP), leads to a robust increase in germ cell apoptosis in 
rats and mice (Boekelheide, 2005). Although it is well established that the cellular 
target of MEHP is the Sertoli cell, the identity of the specific intracellular target 
has remained elusive and MEHP-induced injury does not lead to the death of the 
Sertoli cell themselves. Rather, specific populations of germ cells, the 
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spermatocytes and possibly early round spermatids, undergo apoptosis
 
(Giammona, 2002). Since the functional capacity of the Sertoli cells is critical in 
orchestrating the complex process of spermatogenesis and maintaining the 
viability of the germ cells, it is hypothesized by our group and others that Sertoli 
cells instigate apoptosis as a mechanism to reduce the population of germ cells to 
match the reduced supportive capacity (Boekelheide, 2000), (Richburg, 2002). 
The death receptor DR5 and its ligand TRAIL have been described to be 
highly expressed in the testis of rodents (Grataroli, 2002). Previous observations 
have shown that increases in the expression of DR5 and TRAIL occurs in the 
testis of MEHP-exposed wild-type and gld mice, indicating the possibility that 
TRAIL/DR5 may also play a role in promoting germ cell apoptosis in the testis 
and providing the rationale for the present investigation (Richburg, 2000). As 
seen in the previous chapter, MEHP appears to also increase p53 stabilization and 
higher transcription of DR5 mRNA. This linkage between p53 status and the 
expression of DR5 levels could be an important determinant of germ cell sub-type 
specific apoptosis. Accordingly, in the present chapter, both in vivo and in vitro 
experimental model systems are utilized to investigate if conditions resulting in 
the activation and/or stabilization of the p53 protein both influence the expression 
of DR5 on the germ cell plasma membrane and promote apoptosis in discrete 
testicular cell populations.  
The experiments also sought to determine, for the first time, that germ 
cells, in particular spermatocytes, are able to undergo TRAIL-mediated apoptosis 
and whether pretreatment with agonistic DR5 antibodies synergistically increase 
their sensitivity to TRAIL-mediated apoptosis. Such a finding would have 
implications for current therapeutic approaches that combine DR5 activating 
monoclonal antibodies with chemotherapeutic agents that likely activate p53 and 







A. TRAIL- and DR5-gene deficient mice show no phenotypic alterations in 
testicular morphology  
 
 Mice with a gene deficiency in either DR5 or TRAIL (Fig. 4.1, panel A) 
failed to show any morphological differences in the spermatogenesis of adult 
testis as compared to the matched wild type strain (Fig 4.1, panel B). No changes 
were observed in the fecundity or fertility of these mice as compared to the wild 
type background strain (data not shown).  
 
B. TRAIL induces apoptosis in primary rat testicular germ cells 
 
 Preparations of rat testicular seminiferous tubule explants were used to test 
if exogenously added TRAIL (0.5 µg/ml) could trigger apoptosis of primary germ 
cells. This experimental approach allows for the preservation of the structural 
associations between the Sertoli cells and the germ cells. The total number of 
apoptotic cells per 1 mm segment was measured using the TUNEL assay on 
squash preparations as described by Toppari and Parvinin
 
(Toppari, 1985). The 
number of apoptotic cells in control explants was variable  (90 ± 40) and reflects 
the normal experiment-to-experiment variability in the handling and dissection of 
the tubule segments. (Fig. 4.2) Addition of the caspase-3 inhibitor DEVD (100 
µM) to the media at the time of preparation caused a trend for lower baseline 
apoptosis values (60 ± 30). Addition of 0.5 µg/ml TRAIL induced a significant 
(P-value: ≤ 0.01)  increase in the number of apoptotic germ cells per 1 mm tubule 
segment (260 ± 80), and this robust increase could be inhibited by pre-incubation 




























Fig. 4.1. Testicular histology of wild type mice versus TRAIL deficient and DR5 
deficient  mice. Cross sections of 5 µM thick tissue were treated with PAS & H as 
described in the Methods and Materials. Neither TRAIL- nor DR5-gene deficient 
mice exhibit significant morphological changes under physiological conditions. 
The gene deficient animals were matched with normal testes of animals of the 
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Fig. 4.2 Recombinant TRAIL-induced apoptosis of primary rat testicular germ cells. 
Segments of rat seminiferous tubules (1 mm) were isolated and maintained under serum 
free conditions as described in Material and Methods. TRAIL (0.5 µg/ml) was added to 
the media and germ cell apoptosis was assessed after 6 h by the TUNEL assay on squash 
preparations. Methyl green was used as a counterstain. For some experiments isolated 
tubule segments were pretreated with 100 µM z-DEVD-FMK for 1 h before TRAIL 
addition. *Samples are within standard error (P-value: ≤ 0.01) compared to controls as 











































































































































Fig. 4.3 MD5-1 increases apoptosis in rat seminiferous tubule explants. Explants 
from rats treated with TRAIL induced apoptosis after 6 h as detected by TUNEL. 
A combination of TRAIL (0.5 µg/mL) and DR5 agonistic antibody MD5-1 (0.5 
µg/mL) stimulated apoptosis at a higher rate than TRAIL alone. 
 
Control 









C. DR5 agonistic antibody MD5-1 increases apoptosis in rat seminiferous tubule 
explants 
 
 To determine whether a combination of TRAIL and a DR5 agonist  would 
sensitize germ cells to greater apoptosis, the anti-DR5 antibody MD5-1 was 
administered. Primary rat seminiferous tubule cultures were again used as a model 
and cultured for 10 h prior to toxicant treatments. In the control explants, cell 
death is observed only in the exposed “ends” of the tubules, where germ cells no 
longer have contact with Sertoli cells (Fig. 4.3A, control panel). The body 
maintains proper structural relationships between the cell types and stains positive 
for methyl green but not for apoptosis. Treatments of TRAIL (0.5 µg/mL)  alone 
(6 h) induces positive stain dispersed among the germ cells of the tubule (Fig. 
4.3B, TRAIL). Explants exposed to a combined treatment of TRAIL and MD5-1 
(6 h, 0.5 µg/mL) displayed extensively increased apoptosis throughout the body 
of the tubule (Fig. 4.3C, TRAIL + MD5-1). The tubules were partially protected 
from apoptosis when pre-treated (1 h) with caspase-3 inhibitor, DEVD (not 
shown). 
 
D. TRAIL treatments induced apoptosis in p53 expressing GC-2 cells  in vitro 
 
 Treatments of TRAIL modestly engages the apoptotic program in GC-2 
spermatocyte-like cultured cells as determined by annexin-PI flow cytometry. 
Cell death is detected at 6 h time points in p53 permissive cells maintained at 
32°C (Fig. 4.4A). At non-permissive temperatures (37°C) exogenously added 
TRAIL had little effect on the cells and did not produce significant apoptosis 
(data not shown).  Initial concentrations of .25 µg/uL produced apoptosis at  twice 
the rate of the control and were significant (P-value: ≤ 0.01) compared to the 
control (untreated) sample.  A further concentration of .50 µg/uL further increased 
cell death to 21%, approximately what was obtained when using the Fas-linker 






















Fig. 4.4 TRAIL induces apoptosis in GC-2 cells. (A) Treatments of TRAIL 
modestly engages the apoptotic program in GC-2 spermatocyte-like cultured cells 
as determined by annexin-PI flow cytometry. Cell death is detected by annexin-PI 
flow cytometry at 6 h time points in p53 permissive cells maintained at 32° C. 
Experiment performed by Yang Ye. (B) Membrane DR5 protein elevated in p53 
permissive GC-2 cells. The level of expression of DR5 on the cell membrane were 
determined by surface antigen flow cytometry. *Samples are within standard error 
(P-value: ≤ 0.01) compared to controls as determined by analysis of variance 

















































E.  Cell surface expression of DR5 greater in p53-expressing GC-2 cell lines 
 
  The expression of DR5 on the plasma membrane of GC-1 and GC-2 cells 
(maintained at either 37°C or 32°C) was determined by surface antigen flow 
cytometry. GC-1 cells are of a spermatogonia lineage and are used as a control to 
GC-2-spermatocyte cultures. Only a small percentage (<1%) of GC-1 cells 
revealed positive cell surface expression for DR5 (Fig. 4.4B). However, 10% of 
the GC-2 cell population maintained at 37°C were positive for DR5 expression 
whereas approximately 30% of GC-2 cells maintained at 32°C showed positive 
membrane expression.  
 
F. Cyclohexamide pre-treatment does not significantly enhance GC-2 sensitivity 
to TRAIL-induced apoptosis 
 
 Pretreatment of cells with low doses of cyclohexamide has previously 
been used as a mechanism to sensitize certain cell types to death receptor-induced 
apoptosis (Wajant, 2000), (Kreuz, 2001). Exposure of GC-2 cells (32°C) to 
cyclohexamide for 6 h was found to increase the incidence of cell apoptosis (Fig 
4.5A & B). GC-2 cells that are undergoing apoptosis are easy to discern in cell 
culture due to their loss of adhesion with the matrix on the plate and their 
rounding morphology (Fig. 4.5A). Pretreatment of GC-2 cells maintained at 32°C 
with cyclohexamide and subsequent treatment with TRAIL (0.5 µg/ml) gave an 
additive increase in cell apoptosis indicating that these two agents likely instigate 
apoptosis by two distinct mechanisms. As expected, treatment with 
cyclohexamide, TRAIL, or the combination did not increase apoptosis in GC-1 
cells (Fig. 4.5B, no photomicrograph shown). The lack of cell death in GC-1 cells 




G. DR5 agonistic antibody (MD5-1) pretreatment results in a robust synergistic 
increase in TRAIL-induced apoptosis in GC-2 cells 
 
 The MD5-1 anti-DR5 monoclonal antibody was originally produced in the 
laboratory of Dr. Hideo Yagita of the Juntendo University School of Medicine in 
Tokyo, Japan. It was reported that this antibody exhibited potent anti-tumor 
effects against TRAIL-sensitive tumor cells in mice
 
(Takeda, 2004).  Preliminary 
studies in our laboratory using MD5-1 revealed that pretreatment with this 
antibody caused the GC-2 cells maintained at 32°C to be extremely sensitive to 
TRAIL-mediated apoptosis and required an earlier 2 h time period for analysis of 
germ cell apoptosis. After 2 h of TRAIL exposure of GC-2 cells only a slight 
increase in apoptosis was measured and this could be reduced by exposure to the 
pan-caspase inhibitor z-VAD-fmk (Fig. 4.6A, panel a-c). Treatment of GC-2 cells 
with anti-DR5 alone did not increase apoptosis but, in combination with TRAIL, 
induced substantial amounts of apoptosis and this cell death could be inhibited by 
concurrent z-VAD-fmk treatment (Fig. 4.6A, panels d-f). Quantitation of GC-2 
cell apoptosis shows that nearly 60% of cells that had been pre-treated with anti-
DR5 antibody had undergone apoptosis by 2 hour after TRAIL treatment whereas 
those treated with TRAIL or anti-DR5 alone did not show significant increases in 
apoptosis (Fig. 4.6B). Partial protection could be seen when caspase inhibitor 
ZVAD was used to block the effect, indicating caspase dependent apoptosis. 
However, the inhibitor was not enough to completely abrogate the effect of MD5-
1/TRAIL treatments, which initiates cell death within 30 minutes. 
 Western blotting shows that the MD5-1/TRAIL co-treatment results in 
levels of reduced full-length caspase-8 after treatment and particularly at the p53 
permissive temperature, indicating its activation. (Fig. 4.6C) Associated cleavage 
and activation of caspase-3 also occurs post treatment. These findings supplement 
previous observations that p53 activity is associated with increased caspase 



































Fig. 4.5 Cyclohexamide (CHX) pretreatment causes a modest sensitization of TRAIL-
induced cell death in GC-2 (32° C) cells. (Panel A) Phase-contrast micrographs of GC-2 
cells cultured at 32 °C. Cells were treated with either vehicle (a), TRAIL (0.5 µg/ml) (b), 
CHX (1 µg/ml) (c), or a 1 h pre-treatment with CHX before the addition of TRAIL (d). 
Bar equals 100 µM. (Panel B) GC1 and GC-2 (32°C) cells were treated with vehicle, 
CHX, TRAIL or the combination or CHX and TRAIL as described above and cell 
apoptosis was evaluated after 6 h of exposure via annexin-PI flow cytometric analysis. 
*Samples are within standard error (P-value: ≤ 0.01) compared to controls as determined 
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Fig. 4.6 TRAIL-induced apoptosis of GC-2 (32°C) cells is significantly increased after 
pretreatment with an anti-DR5 antibody. (Panel A) Phase-contrast micrographs of GC-2 
cells maintained in culture at 32°C. Cells were treated with either vehicle (a), TRAIL (0.5 
µg/ml) (b), z-VAD-fmk-FMK (10 µM) and TRAIL (c), agonistic anti-mouse DR5 (MD5-
1) antibody (0.5 µg/ml) (d), the combination of anti-DR5 antibody and TRAIL (e), or a 1 
h pretreatment with z-VAD-fmk-FMK (10 µM) before the addition of TRAIL and anti-
DR5 antibody (f). The images of the cells in culture were captured after 2 h of exposure. 
Bar equals 100 µM. (Panel B) GC-2 (32°C) cells were treated with vehicle, TRAIL, anti-
DR5 antibody  or the combination of the anti-DR5 antibody and TRAIL as described 
above and cell apoptosis was evaluated after 2 h of exposure via annexin-PI flow 
cytometric analysis. TRAIL/MD5-1 treatments preferentially induce caspase-8. 
Treatment of GC-2 cells with Trail (.5 µg) and MD5-1 (.5 µg) induces high levels of 
apoptosis and activated caspase-8 after only 2 h incubations. *Samples are within 
standard error (P-value: ≤ 0.01) compared to controls as determined by analysis of 
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H. Anti-DR5 antibody and p53 activity causes stabilization/clustering of DR5 on 
the cell membrane and increased sensitivity to TRAIL 
 
 Addition of MD5-1 generates cell death in cells grown both at 37° (data 
not shown) and 32° C. Apoptosis is much greater in the cells maintained at 32°C 
where p53 activation and nuclear localization occurs (Fig. 4.6 A & B). 
Immunocytochemical staining and confocal microscopy of DR5 in the 37° sample 
(Fig. 4.7A; limited p53 expression and no MD5-1 treatment) is light and diffused 
randomly about the membrane surface. Further evaluation demonstrated that an 
increase in the p53 activation in GC-2 cells correlated with higher DR5 levels on 
the membrane at 32°C (Fig. 4.7C). Treatments with MD5-1 promote the 
aggregation and organization of DR5 receptor proteins into denser regions along 
the surface of the plasma membrane, even in cells that express less p53 (Fig. 
4.7B). However, elevated p53 expression in the cells maintained at 32°C 
increases DR5 localization to the membrane and GC-2 cells become notably more 
sensitive to MD5-1 treatment and subsequent TRAIL addition (Fig. 4.7D). Cells 
exposed to this combined treatment were rapidly killed after only a 2 h treatment 















































Fig. 4.7. DR5 agonist antibody MD5-1 and p53 are able to increase and 
cluster DR5 on the membrane of GC-2 cells. Immunocytochemistry of GC-2 
cells grown at both p53 permissive (32ºC) and non-permissive (37ºC) 
temperatures. Cells were grown on chamber slides for 24 h before detection 
with an anti-DR5 primary antibody and Alexa Fluor 488 secondary antibody.  
Treatments were conducted for two hours. Slides were mounted using Vector 
mount containing PI to stain the nucleus and all samples were analyzed via 
confocal microscopy. Panel A shows cells grown at 37ºC without treatment 
while panel B indicates cells at 37ºC after treatment with anti-DR5 antibody 
MD5-1 and TRAIL. GC-2 cells were also gown at the p53 permissive 
temperature without any treatment (panel C) or with MD5-1 antibody and 
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 4.3. Discussion 
 
The ability of TRAIL to trigger apoptosis in non-tumorigenic cells is rare. 
Hepatocytes appear to be a major exception to this rule (Lawrence, 2001), (Mori, 
2004). In addition, resting lymphocytes may be also susceptible to TRAIL-
mediated apoptosis under some physiological conditions (Meurette, 2006). 
However, normal germ cells have never been shown to undergo apoptosis though 
this pathway. In this chapter, evidence is presented showing primary germ cells 
explants undergoing cell death mediated by addition of human TRAIL. 
Furthermore, in GC-2 cells TRAIL-mediated apoptosis is further mitigated by p53 
activity and is dramatically augmented by the DR5 agonistic antibody, MD5-1. 
Seminiferous tubule explants represent a 1 mm length of testicular cells 
removed from the testis and cultured for a short time (10 h) in media. The use of 
explants allows for the easy delivery of agents to the cells of the seminiferous 
tubule without instigating a disruption of the intimate associations between Sertoli 
cells and germ cells. Addition of exogenous recombinant TRAIL (0.5 µg/mL) 
protein was able to induce a 3-fold elevation in germ cell apoptosis (Fig. 4.1). The 
TRAIL mediated germ cell apoptosis was significantly inhibited by the caspase-3 
inhibitor DEVD (Fig. 4.1) demonstrating its dependence on caspase activation. 
This is the first time TRAIL has been shown to trigger cell death in primary 
testicular cells. Although TRAIL was able to cause increases in germ cell 
apoptosis in this in vitro tissue model, direct injection of TRAIL into the testis 
was not found to cause increases in germ cell apoptosis (data not shown). These 
findings may indicate that TRAIL may only be able to instigate apoptosis in germ 
cells that have undergone secondary changes due to cellular stress, such as that 
which occurs during the preparation of the tissue explants.  
In the testis, apoptosis of germ cells normally occurs under physiological 
conditions and is speculated to control the numbers of germ cells to match the 
supportive capacity of the testis (Print, 2000). In previous studies, the functional 
participation of another death receptor ligand system, the FasL/Fas system, has 
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been shown to induce testicular germ cell apoptosis in rodents after exposure to 
the Sertoli cell toxicant MEHP. A functional FasL/Fas signaling system, however, 
does not appear to be a requirement for physiological apoptosis in the testis as 
mice expressing mutant forms of these proteins or with a gene deficiency are still 
fertile and show normal spermatogenesis.  
Similar to these observations, the mice that are gene deficient for TRAIL 
or DR5 show apparently normal levels of fertility (unpublished observations from 
our mouse colony). In addition, mice deficient for either TRAIL or DR5 do not 
exhibit unusual levels of apoptosis or display morphological derangement under 
physiological conditions (Fig 4.2, panels A & B). Therefore, TRAIL/DR5 
induced apoptosis of testicular germ cells is not an absolute requirement for the 
physiologic control of germ cell apoptosis in the testis. Howerver, TRAIL and 
DR5 are kown to be expressed at a high rate in germ cells (Grataroli, 2002), 
(Giammona, 2002). Taken together with our present findings indicating that 
TRAIL induces germ cell death, this has led us to hypothesize that alterations in 
germ cells occur only after distinct testicular stress/injury. Our finding that 
TRAIL was only able to induce apoptosis in explants of testicular seminiferous 
tubules and not in the intact testis in vivo is in agreement with this hypothesis. 
An exciting additional find was that the combination of TRAIL and DR5 
agonistic antibody (MD5-1) resulted in a much higher apoptotic response in 
primary tubule cultures than just TRAIL alone (Fig. 4.3B). Ordinarily, healthy 
tubules will only demonstrate apoptosis on the exposed “ends,” (small arrows) 
whose germ cells have lost contact with the supporting Sertoli cell (Fig. 4.3A) 
Eventually, these cells die from lack of nutrients or some other stress related to 
Sertoli cell dissociation. However, the body of the tubule maintains Sertoli cell-
germ cell structural integrity and no apoptosis occurs in untreated cultures. 
Addition of 0.5µg/ml of TRAIL increases the incidence of germ cell death in the 
tubule body (large arrows). Combined treatment with both TRAIL and MD5-1 
significantly increases this cell death and apoptotic positive germ cells can be 
seen throughout the tubule (Fig. 4.3C).  
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In order to discern the cellular determinants of germ cell sensitivity to 
TRAIL we utilized germ cell-derived cell lines GC-1 (spermatogonia-like) and 
GC-2 (spermatocyte-like). Initial experiments determined that human TRAIL 
sensitized p53 permissive GC-2 cells to moderate apoptosis (Fig. 4.4A). We have 
previously demonstrated that GC-2 are differentially sensitive to Fas-induced cell 
death coincident to their p53 status. Here we show that GC-2 cells maintained at 
the p53 permissive temperature exhibit the highest membrane DR5 levels (30%) 
among the cells examined, as determined by flow cytometry (Fig. 4.4B).  Both 
the spermatogonia-like GC1 cells and GC-2 cells maintained at the non-
permissive p53 temperature expressed considerably less DR5 protein on their cell 
membranes (<1% and 10% expression respectively). These differences in 
membrane DR5 expression correlate well with their sensitivity to TRAIL-
mediated apoptosis, indicating that the sensitivity of the spermatocytic population 
of germ cells is closely associated with receptor expression on the cell membrane.  
The use of antibodies directed against the TRAIL receptors DR4 or DR5 
as strategies to treat cancer has been previously explored and a number of groups 
have specifically used DR5-specific monoclonal antibodies (Ichikawa, 2001), 
(Guo, 2005). Here we used the agonistic anti-DR5 monoclonal antibody MD5-1 
to investigate its ability to induce DR5 mediated apoptosis in the GC-2 germ cell 
lines. The above experiments with tubule cultures indicated that germ cells were 
sensitive to apoptosis via the TRAIL/DR5 system and also that a caspase blocker  
(DEVD) would protect against cell death.  
The in vivo results were validated in GC-2 cells. The results showed that 
although addition of TRAIL alone induces modest increases in cell death, addition 
of the MD5-1 was able to generate a robust synergistic increase in germ cell 
apoptosis (Fig. 4.6A). Treatment with MD5-1 elevated the incidence of germ cell 
apoptosis by four-fold within two hours of addition, resulting in an apoptotic 
incidence of nearly 60%, compared to the control, TRAIL only treatment, or with 
MD5-1 only (12, 15, and 13% respectively). We also show here that in cultured 
GC-2 cells treated with TRAIL and agonistic antibody, caspase activation of the 
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extrinsic pathway is induced, as seen by the robust reduction of full-length 
caspase-8. Additionally, induction of the effector caspase-3 is only observed in 
GC-2 cells treated with both TRAIL and the DR5 agonist, MD5-1. Caspase 
inhibitor z-VAD-fmk was able to at least partially block the effect of 
TRAIL/MD5-1 (Fig 4.6B). 
These experiments contrasted with the six hour time points needed to 
observe significant cell death in the experiments using cyclohexamide (CHX), a 
protein translation inhibitor widely employed to sensitize cells to TRAIL-
mediated apoptosis (Wajant, 2000), (Kreuz, 2001). Although TRAIL or 
cyclohexamide treatment alone was able to induce moderate increases in 
apoptosis in GC-2 cells maintained at the p53-permissive temperature (Fig. 4.5B), 
the combination of the two together did not result in a synergistic effect but rather 
a simple additive effect. This indicates that MD5-1 and cyclohexamide addition 
may induce apoptosis via independent mechanisms.  
To explain the influence of MD5-1 on the sensitivity of DR5 to TRAIL 
activation we tested whether MD5-1 was simply acting to stabilize and/or cluster 
DR5 trimers on the cell membrane. Trimerization of DR5 receptors, as with Fas 
receptors, is required for efficient activation of procaspase-8 in the DISC 
(Schulze-Osthoff, 1998). Poor or low clustering of death receptor proteins impede 
the formation of the DISC at the membrane and therefore little catalytic cleavage 
of procaspse-8 into its active form. To assess this possibility we performed 
immunocytochemical analysis of DR5 in GC-2 cells at both the p53 permissive 
and non-permissive temperatures after treatment with MD5-1, TRAIL, or a 
combination of both. Visualization of the cells via confocal microscopy showed 
evidence that cells grown under p53-permissive conditions expressed a 
considerably increased level of DR5 on the cell membranes than did cells grown 
at 37°C (Fig. 4.7A & C). Cells grown at 37°C could also show elevations in DR5 
on the membrane if followed with administration of MD5-1, although the receptor 
increases were not robust. The DR5-agonist potentially acts to cluster the smaller 
amount of receptor protein on the membranes of these cells. The combination of 
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p53 expression and MD5-1 (Fig. 4.7D) induced a highly elevated level of 
membrane DR5 and this likely results from both increased transcription of DR5.  
For apoptosis to occur, DR5 levels are already present on the surface of 
the germ cell, likely pre-associated into trimers or clusters of trimers as Fas 
receptors are known to do. MD5-1 may act to aid in the clustering of multiple 
death receptor trimer sites. In favor of our hypothesis, the confocal microscopy 
results show not only more DR5 expression but tighter overall organization of the 
staining in p53 permissive cells. This effect has been previously seen in apoptotic 
cells with Fas receptor “capping” (Cremesti, 2001). Therefore, when TRAIL is 
added exogenously to the cells, the ligand is able to interact with “groups” of 
trimerized receptors and apoptotic induction can occur at a very rapid pace. In 
addition, the vigorous pro-death signal may displace the anti-apoptotic c-FLIP 
protein and generates high levels of apoptosis. These data, taken together, indicate 
that the expression of DR5 on the membrane of germ cells is positively associated 
with the transcriptional activity of p53 and that the anti-DR5 antibody is a strong 
sensitizer of membrane DR5 to TRAIL-induced apoptosis. 
The current study is important because of its identification of defined 
germ cell sub-populations (spermatocytes) sensitive to specific apoptotic 
regulation and a method by which to sensitize this population to TRAIL/DR5 
dependent cell death. In addition, p53 activation is critical in the induction of 
apoptosis both in vivo and in vitro. The data indicates that under physiological 
conditions TRAIL and DR5 do not cause germ cell death. Rather, cell stress 
associated with chemotherapeutic agents or toxicant exposures is required to 
induce the observed sensitivity. These findings have implications for current 
chemotherapeutic approaches that combine DR5 activating monoclonal antibodies 







Regulation of Germ Cell Apoptosis by Ubiquitinylation 
 
5.1. Introduction and Rationale 
   
 In the previous chapters, it has been shown that MEHP triggers the p53-
dependent expression of Fas and DR5 and that the initiation of apoptosis occurs 
through the extrinsic pathway. However, regulatory barriers exist in the pathway 
to safeguard the cell against unimpeded apoptosis. One such element is the c-
FLIP protein, a major determinant of cell survival in response to death receptor 
mediated apoptosis. The ratio of c-FLIP protein to procaspase-8 present at the 
DISC is an important indicator of whether the cell will survive or undergo cell 
death. If the balance is tipped towards caspase-8 activation and apoptosis, c-FLIP 
is thought to be degraded through the ubiquitin-proteasome pathway. However, to 
date, the specific proteins responsible for targeting c-FLIP for degradation in 
germ cell apoptosis is unknown. This chapter examines the possible participation 
of an E3-ligase containing protein, Itch, in the sensitivity of spermatocytes to 
undergo cell death. 
 The ubiquitin-proteasome system is the most common method of protein 
degradation in the cell. Ubiquitination is ATP dependent and requires three 
intermediate enzymes: E1 (transferring), E2 (conjugating), and E3 (ligating), with 
the E3 ligase determining protein specificity (Haglund, 2003). The process of 
degradation is mitigated through the deposition of individual  ubiquitin  molecules 
through a particular lysine residue and onto a targeted protein. Multiple additions 
of ubiquitin through the same amino acid will eventually produce a chain of four 
or more that signals the identified protein for degradation (Pickart, 2001).  
 There are two classes of E3 ligases: RING (really interesting new gene) 
and HECT (homology to E6-AP carboxyl terminus) (Sun, 2003). HECT E3 
ligases directly transfer ubiquitin to the substrate molecule whereas RING assists 
its conjugate E2 enzyme in this transfer. However, in both classes the poly-
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ubiquitinylated protein is directed to the 26s proteasome, a large cytosolic 
complex that is capable of proteolysis and regeneration of constitutive amino 
acids. 
  Numerous proteins intimately involved with the apoptotic process are 
regulated through ubiquitinylation, including but not limited to p53, several 
members of the caspase family, and various BCL-2 proteins (Yang, 2000), 
(Orlowski, 1999), (Yang, 2003). Despite mounting evidence that c-FLIP is post-
transcriptionally controlled via a ubiquitin ligase, no candidate proteins were put 
forward until the E3 ligase activity of Itch was associated with increased 
sensitivity to cell death in mouse hepatocytes (Chang, 2006). Itch was 
subsequently shown to promote liver cell apoptosis induced by TNF-alpha, 
possibly as a consequence of specifically targeting c-FLIP for degradation. Itch is 
a multi-functional protein that contains a HECT E3 ligase. The protein has been 
previously implicated in the regulation of specific immunity, development, and 
most recently, apoptosis (Kostianovsky, 2007), (Di Marcotullio, 2006). An 
established line of Itch protein deficient mice, Itchy, has been frequently 
employed as an autoimmune disease model, as Itch influences T-cell 
differentiation and auto-immunity (Perry, 1998), (Matesic, 2006). Furthermore, 
the ligase has been shown to undergo activation by way of JNK1-mediated 
phosphorylation, on one or more of three amino acids: serine-199, threonine-222, 
and serine-232 (Gao, 2004). 
 Fas is a member of the TNF-alpha family of receptors and is an 
established inducer of apoptosis in a variety of cell types, including germ cells. In 
addition to recruiting and interacting with members of the DISC, expression of 
the death receptor has been shown to promote JNK1 activation, a MAP (mitogen 
activated protein) kinase also responsible for activating Itch (Toyoshima, 1997), 
(Schwabe, 2004). Therefore, induction of Fas may not only induce the DISC and 
caspase cleavage but also stimulate the downstream phosphorylation of Itch and 
its ability to ubiquitinylate specific protein targets. Following this reasoning, a 
hypothesis was advanced surmising that increases in Itch activation would occur 
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following treatments with MEHP, a known inducer of death receptors in germ 
cells. A further postulation is that the stabile expression of p53 would be 
necessary for the efficient induction of this process given the data obtained in the 
previous chapters. 
 We propose here, for the first time, that Itch may play a role in the 
regulation of c-FLIP and germ cell apoptosis. Occurrence of c-FLIP 
ubiquitinylation in the GC-2 cell line is shown to correlate strongly with the 
expression of p53 and in concert with apoptosis. Cell death has been observed in 
the testicular tissues of wild type mice after exposure to the toxicant MEHP. Here 
we show that cell death in spermatocytes is coincident with the activation of Itch 
and the reduction of c-FLIP. Furthermore, we show that Itch deficient mice 
express more c-FLIP than wild type strains. Administration of MEHP in Itchy 
does not significantly increase apoptosis in these mice and at least partially 
protects against the massive germ cell loss seen in treated wild type strains. 
 However, we also observe that Itchy animals display an increased 
incidence of apoptosis in a spermatocyte stage distinct from those killed by 
MEHP. In addition, blocking Itch activation or reducing cellular transcript levels 
via siRNA did not reduce apoptosis in GC-2 cells, suggesting that other functions 
in the cell are effected if Itch is reduced. Since the largest percentage of the cells 
undergoing apoptosis in vivo are in metaphase, Itch may play a role in the cell 
cycle. In support of this observation, Itchy mice maintain high levels of cyclin B1, 
a protein that must be degraded for the progression from metaphase to anaphase. 
Therefore, our investigations may have also uncovered a previously undescribed 










A. FLIP is present in the testis as the long isoform and is processed after 
MEHP treatment 
 
 Usually, c-FLIP exists in the cell as a long (56 kD) or short (28 kD) 
isoform. Western blots of testis from MEHP-treated mice reveal that the c-FLIP 
protein is expressed in the testis primarily as the long form, with little detection of 
the ~28 kD short isoform. When the long form c-FLIP is present at the DISC, it is 
cleaved once by caspase-8, forming a p43 fragment that remains attached to 
FADD (Scaffidi, 1999). Processing is most robust concomitant with p53 
expression, as the p43 fragment is reduced in p53-/- mice (Fig. 5.1). Caspase-8 
cleavage is evidently concurrent with these processed forms, suggesting that both 
procaspase-8 and c-FLIPL are located in the DISC simultaneously. However, full-
length c-FLIPL is present in only moderate amounts in the control and is reduced 
in samples treated with MEHP at 12 and 24 h (Fig. 5.1). The results indicate that 
c-FLIPL is a fast turn-over protein that can be down-regulated after MEHP 
exposure. 
 
B. Ubiquitinylation of c-FLIP is increased following Fas triggering and p53 
expression in vitro 
 
 To determine if c-FLIPL undergoes post-translational modification by 
ubiquitin, c-FLIPL was immunoprecipitated from lysates of GC-2 cells following 
exposure to the Fas-activating antibody, Jo2. Immunoprecipitated complexes were 
probed using the anti-c-FLIP rat monoclonal antibody or ubiquitin (see Methods). 
The complexes collected through this procedure, upon being analyzed by western 
blot analysis, showed that cells at the p53 permissive temperature (32° C) had 
more extensive ubiquitin-tagged c-FLIPL than cells at the non-permissive 
temperature (Fig. 5.2A). Polyubiquitinylated forms of c-FLIPL were revealed as 
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discrete bands with molecular weights of >60 kDa on the western blot that 
corresponded to the predicted mass of C-FLIPL plus ubiquitin (Fig. 5.2A). 
Polyubiquitinylated levels of c-FLIPL were low in GC-2 cells grown at the p53 
non-permissive temperature, but detectable levels were observed after Jo2 
addition (Fig. 5.2A, 37° C). Cells cultured at the p53 permissive temperature 
exhibited a higher basal level of ubiquitinylation, which also increased after Jo2 
treatment (Fig. 5.2, 32° C). However, c-FLIPL was similarly expressed at the 
permissive temperature in the absence of Jo2 treatment. Thus, p53 expression is 
an important factor in the degradation of the protein. Four or more protein bands 
approximately 8.5 kDa apart in addition to the naïve c-FLIPL protein band were 
generated, corresponding to the sizes expected for ubiquitin-tagged c-FLIPL 
protein (Fig. 5.2). 
 To validate the results,  c-FLIP immunocytochemistry was performed on GC-
2 cells maintained under both growth conditions without Jo2. Fluorescent 
detection of the c-FLIP protein was evident at the p53 non-permissive 
temperature and localized to the cytoplasm (Fig. 5.2B, left). In contrast, pre-
existing c-FLIP was much less pronounced, even without administration of Fas-
linker Jo2, when grown at the p53 permissive temperature (Fig. 5.2B, right). 
Thus, a causal link can be established between the expression of p53 and the 



























Fig. 5.1 c-FLIP is expressed in testis primarily as the long form and is reduced 
after MEHP. The long (56 kD) isoform of c-FLIP is reduced upon administration 
of MEHP in wild type mice but to a lesser extent in p53-/- animals. The presence 
of the c-FLIPL p43 processed form is also decreased in p53-/- mice. Very minor 
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Fig. 5.2 c-FLIPL ubiquitinylation in GC-2 cells is p53 dependent. (A) 
Immunoprecipitation of GC-2 cells grown at non-permissive (37°C) and permissive 
(32°C) temperatures show a correlation between c-FLIPL ubiquitinylation and p53 
expression. Pull-downs were performed in cell lysates as described in the Methods 
and Materials. Fas-linking antibody Jo2 (5 µg/ml) was used to supplement apoptosis 
but did not have a major influence. (B) Immunofluorescent detection of c-FLIPL in 
GC-2 cells at both temperatures. Cytoplasmic levels of c-FLIPL are decreased when 
p53 is expressed. 
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C. c-FLIPL levels are reduced in the presence of activated Itch in vivo 
 
   Whole testis from MEHP-treated wild type and p53-/- mice were 
homogenized and analyzed as described previously. Total Itch protein was 
expressed in the testis of both mouse strains and under all treatment conditions. 
Itch levels seem to decrease with MEHP exposure, perhaps correlating with its 
increased phosphorylation. To determine if Itch was activated at the same time 
points, an antibody against phospho-threonine-222 was used on the same samples. 
Threonine-222 is one of three amino acid residues (ser-199, thr-222, ser-232) that 
are commonly phosphorylated upon Itch activation (Gao, 2004). A steady 
increase in Itch activation was observed until very high levels were detected by 24 
hours (Fig. 5.3A). This may explain why total Itch detection decreases, as the 
antibody detects a region (between amino acids 114-230) of the protein known to 
be phosphorylated. Additionally, the Itch activity corresponds to the activation of 
JNK1, a MAP kinase believed to the principle regulator of Itch phosphorylation. 
Interestingly, phospho-JNK 2/3 also increased slightly and are expressed at high 
levels. Correspondingly, c-FLIPL levels were reduced during the same time points 
as Itch/JNK1 were active in the wild type mice (Fig. 5.3A, left). The data suggests 
that decline of c-FLIPL protein and activation of Itch could be inversely 
proportional.  
   To assess whether the reaction was p53 dependent, p53-/- mice were also 
treated with MEHP (Fig. 5.3A, right). Itch is expressed in a uniform fashion 
regardless of treatment time points. Itch phospho-threonine-222 levels increased 
slightly but with less significance compared to the wild type mice. Likewise, c-
FLIPL levels were largely unchanged and support the previously obtained GC-2 
cell culture data in which p53 activation promotes c-FLIPL degradation. c-FLIPL 
is more highly expressed in the p53 deficient tissues than in comparable wild type 
samples, implying that p53 is an influence on the stability of c-FLIPL protein in 






















Fig5.3 MEHP-mediated c-FLIP reduction p53-dependent and Itch associated. (A) 
Wild type mice display a correlation between the activation of Itch and MEHP 
treatments. The activation correlates with increases in the MAP kinases JNK1/2/3 
and a decrease in c-FLIPL. In p53 deficient mice, Itch activation is lessened in 
response to MEHP and c-FLIPL levels are stabile. (B) Itch is localized to the 
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  MEHP-mediated degradation. Interestingly, no JNK1 was detected in p53 
deficient mice, but JNK2/3 levels remained high.  
 
D. Itch protein is increased and localized to the cytoplasm following MEHP  
 treatment 
 
  Wild type mouse testis display a low but detectible level of Itch protein as 
determined by fluorescent immunohistochemistry. Mice exposed to MEHP for 24 
hours stained strongly positive for Itch, particularly within the cytoplasm of 
spermatocytes (Fig. 5.3B). Itch protein localization to the spermatocyte at this 
later time point is consistent with increases in p53, death receptor expression, and 
apoptosis shown in the previous chapters.  
  
E.   Morphological staining shows partial protection from MEHP in Itchy  mice 
 
 Morphological staining with periodic acid-Schiff’s/hemotoxylin staining 
showed considerable germ cell loss, vacuolization, and Sertoli cell damage 
associated with MEHP treatment when adult wild type (Fig. 5.4, panel A) mice 
were treated at a 12 hour time point, consistent with previous results (Fig. 3.1). 
Mice lacking the functional Itch gene showed a moderate reduction in germ cells 
under control conditions, particularly spermatocytes and round spermatids, but 
were otherwise morphologically normal  (Fig. 5.4, panel C). Itchy mice treated 
over a similar time course as the wild type displayed increased average lumen 
sizes, suggesting Sertoli cell cytoplasm reduction. However, the tubules of these 
mice displayed less damage structurally overall than the wild type samples and 
germ cell loss is minimal (Fig 5.4, panel D), suggesting that Itch removal confers 
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Fig. 5.4 Itchy mice are partially protected from MEHP treatments. PAS/H 
stained paraffin-embedded tissue shows severe morphological changes in 
MEHP treated WT mice at 12 h (B). Itchy mice (C) show decreases in 
total germ cell numbers denoted by larger lumen size and in particular the 
loss of round spermatids but are otherwise morphologically similar to the 
wild type tubule (A). Itchy mice maintain better structural integrity and 
exhibit less vacuolization after MEHP (D), although average lumen sizes 
are increased. 
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Fig. 5.5  Itchy mice express more testicular c-FLIPL but caspase levels remain 
high. The testis of Itchy mice express higher levels of the c-FLIPL protein as 
determined by western blot. Levels of active caspase-8 (p18) increase in wild type 
mice following MEHP. However, basal levels of p18 are high in Itchy control 
mice although MEHP-mediated morphological damage is not observed (Fig. 5.4).  
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Fig. 5.6 (A) Itchy mice show spermatocyte apoptosis distinct from MEHP mediated cell 
death. Itchy deficient mice have higher rates of apoptosis, with or without MEHP 
treatment (III & IV). The germ cells undergoing apoptosis post-MEHP are early 
spermatocytes in normal WT mice (II). In Itchy mice, cell death is large pachytene 
spermatocytes and are concentrated (>50%) in meiotic cells undergoing metaphase 
(expansion). (B) Itchy mice express elevated cyclin B1. The cycle checkpoint  protein 
cyclinB1 is associated with metaphase blocking. CyclinB1 protein concentrations are 
higher in Itchy mice compared to wild type, indicating an inability of the cells to progress 
into anaphase.  
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F. Itchy mice express more c-FLIPL but are susceptible to apoptosis through 
meiotic arrest 
 
 Western blots of Itchy testicular lysates show an increased expression of c-
FLIPL protein as compared to wild type tissues, indicating that Itch may interact 
with and regulate the level of the protein (Fig. 5.5). Moreover, activated cleaved 
caspase-8 (p18) was detected substantially elevated after MEHP exposure in wild 
type mice, whereas Itchy mice did not exhibit a large change in caspase activation 
post treatment (Fig. 5.5). However, caspase levels in Itchy were already high 
despite  increased c-FLIPL levels, suggesting the extrinsic apoptotic program was 
engaged without addition of the toxicant. These results could indicate that 
apoptosis is occurring independent of MEHP-mediated toxicity and may be the 
result of another physiological factor. 
 To determine if c-FLIPL protects Itchy mice from apoptosis, in situ 
detection of DNA fragmentation (TUNEL) was performed on adult Itch deficient 
mice and adult wild type controls, with and without a 12 hour MEHP treatment. 
Wild type mice showed apoptosis in early (possibly leptotene) spermatocytes of 
stage 7 or 8, the sub-population of germ cells most sensitive to MEHP (Fig. 5.6, 
panel II). Microscopic analysis shows that apoptosis was more prominent in 
slightly more mature spermatocytes, such as the pachytene spermatocyte sub-
populations, in Itchy mice. (Fig. 5.6, panels, III & IV). In addition, the 
seminifierous tubules of the Itchy mice  demonstrated higher basal levels of cell 
death in non-treated controls than wild type mice treated with MEHP for 12 h. 
However, the addition of MEHP did not significantly increase the number of 
apoptotic tubules in Itchy animals. The results indicate that MEHP may be 
inducing apoptosis through a different mechanism than the overall loss of Itch. 
 To investigate if the apoptotic germ cells showed different phenotypes, a 
closer microscopic observation and analysis of Itchy apoptotic cells reveal that 
greater than 50% are arrested at metaphase (Fig. 5.6, expansion). Levels of round 
spermatids, the germ cell formed after meiotic division occurs in spermatocytes, 
are also lower in Itchy mice. Such a result would indicate that Itch may be 
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essential for the completion of the meiotic process. Several proteins are required 
for transmission from metaphase to anaphase in meiosis, particularly cdc2 and 
cyclinB1. To test if the removal of Itch correlated with changes to either of these 
proteins, Itchy lysates were run on a western blot and probed with an antibody to 
cyclin B1. Cyclin B1 is a cell cycle checkpoint protein that must be degraded for 
the progression from metaphase to anaphase in testicular germ cell meiosis 
(Chapman, 1994). Cyclin B1 was higher in the c-FLIPL mice compared to the 
wild type mice (Fig. 5.6B). In both wild type and Itchy mice, addition of 12 h 
MEHP treatments slightly lowered cyclin levels, perhaps due to germ cell death 
associated with the toxicant.  
 
G. RNAi of ITCH in GC-2 cells promotes apoptosis  
 
 To determine whether dysfunctional Itch protects from or sensitizes 
apoptosis in vitro, GC-2 spermatocyte-like cells were utilized. Disruption of Itch 
mRNA in GC-2 cells was accomplished using a specific siRNA delivered by an 
amine tranfection vector. Two principle concentrations of Itch siRNA were used, 
1 µM and 100 nM. The knockdown was effective at both p53 permissive (32°C) 
and p53 non-permissive (37°C) temperatures (data not shown), with the 1 µM 
concentration especially effective. The experiments showed high levels of 
apoptosis associated with Itch knockdowns at both temperatures as determined by 
visual inspection (observation). GC-2 cells grown under at either temperature 
showed elevated incidence of apoptosis as determined by annexin-PI flow 
cytometry (Fig. 5.7). When p53 is minimally expressed, removal of Itch induced 
moderate levels of apoptosis. However, when p53 is active Itch deficient cells are 
sensitized to especially heavy apoptosis. Thus, the presence of active p53 may 
play a significant role in the apoptosis of Itch deficient mice, although the 
mechanism is unknown at this time. Thus, in the event that Itch is reduced or 
removed to the system, a redundant pathway to apoptosis may in fact be triggered, 








      
 
 
Fig5.6 RNAi of ITCH in GC-2 cells promotes apoptosis. Knockdown of the Itch 
gene results in higher levels of apoptosis in GC-2 cells at concentrations as low as 
100 µM. Treatment with Jo2 (5 µg/ml) increased the overall apoptotic effect. Cell 
death is especially prevalent in cells expressing high levels of p53. Statistical 
significance was obtained using ANOVA and Fisher’s PLDS. The graph 
represents three separate experiments. 
 
 






















*  * 
* 
* 







 Many short-lived proteins are regulated through the ubiquitin-proteasome 
system of degradation. Ubiquitinylation, together with phosphorylation, 
represents the most common method of post-transcriptional protein regulation in 
the cell. c-FLIP is an anti-apoptotic protein that functions as a competitive 
inhibitor to caspase-8 at the DISC (Irmler, 1997). The protein is also subject to 
rapid turn-over in the cell and past studies have shown that over-expression of c-
FLIP is associated with tumor progression (Wajant, 2003). Therefore, cellular 
mechanisms must be in place to prevent inappropriate expression of the protein, 
such as by ubiquitinylation.  
 In most cells c-FLIP is expressed as one of two (or both) forms, long (56 
kD) and short (28kD), although a third isoform (c-FLIP-R) has been detected in 
leukocytes only (Golks, 2005). In mouse testis lysates, the long isoform was 
predominantly detected, with very weak staining of the short form (Fig 5.1). c-
FLIPL is known to heterodimerize at the DISC with procaspase-8, leading to both 
a c-FLIPL cleavage (producing a p43 product) and the first procaspase cleavage 
(producing its own p43/41 and p12 products). The c-FLIPL p43 fragment remains 
bound to FADD and prevents any further procaspase-8 from binding to the DISC. 
The short form (c-FLIPs) lacks a death domain so no cleavage occurs and the 
short protein only is detected (Scaffidi, 1999). 
 Full-length c-FLIPL (55 kD) was detected in mouse wild type testicular 
tissues and its level decreased in response to MEHP. An evaluation of c-FLIP 
cleavage products shows that the p43 processed fragment of the long form is 
generated with or without the addition of MEHP. The prominent banding pattern 
of cleaved fragments suggests that c-FLIPL resides preferentially at the DISC, 
where it is processed once (Fig. 5.1). FLIPs was not significantly detected in the 
testicular lysates analyzed. Therefore, FLIPL  is the major isoform found in the 
testis and is subject to post-transcriptional modifications such as ubiquitinylation. 
 The level of activated caspase-8 increases in the testis of mice treated with 
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MEHP, with the active fragment (p18) most prominently observed at 12 hours 
(chapter three). The processing of c-FLIPL remained high in the control, but was 
decreased following MEHP. Thus, less full-length c-FLIPL may reside at the 
DISC following toxicant exposure, possibly due to degradation. This effect is 
lessened in p53-/- mice treated with MEHP, again suggesting a link between the 
p53 protein and apoptosis in germ cells. The reduction in processed c-FLIPL in 
this case could suggest that less caspase-8 is competing for space within the 
DISC. Alternately, less DISC may be formed without the increase in death 
receptors induced by p53 activity, as discussed in previous chapters. 
 The degradation of c-FLIPL by the proteasome was initially proposed by 
Fukazawa et al in the investigation of colon cancer cells and their resistance to 
apoptosis (Fukazawa, 2001). Other studies examining mouse testis detected lower 
c-FLIPL levels when death receptor-mediated apoptosis was induced 
(Chandrasakaran, 2005). To determine if FLIPL is being degraded post-
transcriptionally, we performed immunoprecipitation experiments to detect 
ubiquitinylation of the protein in GC-2 cells after Jo2 exposure at both permissive 
(32° C) and non-permissive  (37° C) temperatures (Fig. 5.2).  
 In cells grown at the nonpermissive p53 temperature, ubiquitin protein 
complexes were isolated by the anti-FLIP antibody/IgG beads and identified by a 
ubiquitin recognizing antibody. At 37° C, ubiquitinylation could be easily 
detected only after a six hour Jo2 treatment, indicating that FLIPL was less 
efficiently tagged for degradation in these cells (Fig. 5.2A). Death receptors are 
expressed to a lower degree at the non-permissive temperature (Fig. 3.3B) and 
seems to require additional Fas activation (by way of linking Fas trimers) to 
induce ubiquitinylation, accomplished by the administration of Jo2 antibody. 
Ubiquitinylation was much more pronounced at the permissive temperature, 
suggesting that the process was augmented by the activity of the p53 transcription 
factor (Fig. 5.2A). Jo2 may contribute to the overall apoptosis in the cells by 
helping to organize the Fas receptors into clusters of trimers, as discussed in the 
previous chapter with the MD5-1 antibody. However, the more important factor 
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in promoting ubiquitinylation appears to be the distinction between the p53 
permissive and non-permissive conditions.  
 Reduction of c-FLIP levels at the permissive temperature strengthens the 
argument that robust apoptosis in spermatocytes is p53-dependent. 
Immunocytochemistry was performed on GC-2 cells using a c-FLIP antibody, 
under ordinary permissive and non-permissive growth conditions without a 
toxicant. At 37° C, when p53 expression is low, c-FLIP levels are can be easily 
visualized using fluorescent microscopy (Fig. 5.2B, left). However, increased p53 
at 32° C appears to quench the c-FLIP signal, indicating that the protein has been 
reduced, presumably by ubiquitinylation (Fig. 5.2B, right). However, to date little 
data has been compiled as to what E3 ligase may act to ubiquitinylate c-FLIP.  
 One such candidate would be Itch, which possesses an E3 ligase of the 
HECT family. HECT E3 ligases can receive ubiquitin molecules from a 
conjugating (E2) enzyme and catalytically pass them onto a protein targeted for 
modification with a high level of specificity (Sun, 2003). Itch expression effects 
an interesting range of target proteins, including the hematopoiesis regulator 
Notch1 and epithelial cells (Perry, 1998). The latter specificity manifests a 
phenotype in Itch protein deficient animals, called Itchy, because the mice 
develop a habit of frequently scratching themselves. Itchy mice are moderately 
fertile but die after four to six months due to inflammatory lesions (Matestic, 
2006). Thus, Itch activity impacts the regulation of immune response, including 
marking self-recognizing T-cells for degradation. 
 Recently Itch has been associated with apoptosis through the TNF-alpha 
pathway of apoptosis (Chang, 2006). Specifically, apoptosis is induced by 
reducing c-FLIPL levels at the DISC, possibly by increasing its ubiquitinylation 
though association with the Itch E3 ligase. The prospect that Itch could be 
involved in the regulation of c-FLIPL in spermatocytes was logical given that 
MEHP increases Fas, a receptor closely related in structure and function to TNF-
alpha. In western blots analysis of MEHP-treated mice testis, Itch was expressed 
at all time points (Fig. 5.3A, Itch panel). c-FLIPL levels decrease modestly at 
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concurrent time points, supporting the hypothesis that increases in Itch correlate 
with its degradation (Fig. 5.3A, c-FLIPL panel). In addition, immunofluorescence 
of treated tissues showed significant increases in Itch localization to the 
spermatocyte cytoplasm, the potential site of c-FLIPL ubiquitinylation, and 
perhaps increased protein expression (Fig. 5.3B). Itch is known to undergo self-
targeting for degradation when the protein is in excess (Mouchantaf, 2006). When 
active, such as under stress conditions,  auto-ubiquitinylation may decrease. 
 To further assess Itch activity, its phospho-activation was examined. Itch 
phosphorylation is dependent on the MAP kinase JNK1 and is essential for the 
functional activity of the protein (Gallagher, 2006). At least two of three amino 
acid residues (ser-199, thr-222, ser-232) must be phosphorylated for the Itch E3 
ligase to be functional. Analysis of MEHP treated tissues documented significant 
increases in Itch phospho-threonine-222 as the time course progressed to 24 
hours. Whatsmore, the active phospho-JNK1 protein was detected at the same 
time point (Fig. 5.3A). 
  c-FLIPL degradation appears to be driven by p53 expression or 
stabilization. Comparisons were made between wild type and p53-/- mice after 
both were treated with normal doses of MEHP (Fig. 5.3B). Phospho-JNK1 levels 
were not increased in p53-/- mice, while Itch phospho-threonine-222 was 
minimally increased in compared to the wild type, possibly lending support that 
Fas expression can drive MAP kinase activity (Goillot E, 1997), (Cahill MA, 
1996), (Muhlenbeck F, 1998). Furthermore, in these animals changes in both c-
FLIPL and Itch were static.  
 Itch protein deficient mice (Itchy), were obtained to further assess the 
physiological role of Itch in germ cells. Morphological staining shows that Itchy 
mice have lower germ cell numbers (Fig. 5.4C). The germ cell loss is coincident 
with diminished populations of mature spermatocytes and spermatids, suggesting 
they are being reduced during a physiological process associated with the lack of 
Itch expression. Administration of MEHP produces some morphological 
derangement in the seminiferous tubules of the Itchy mice, such as increased 
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lumen sizes, in addition to the germ cell loss. However, it is important to note that 
they lack the extensive structural damage observed in MEHP treated tubules of 
wild type mice, such as widespread vacuolization, considerable Sertoli cell 
cytosol reduction, and missing stages. Thus, Itchy mice are at least partially 
protected from MEHP-mediated morphological damage. 
 Lysates from the testis of Itchy animals showed comparatively higher 
amounts of c-FLIPL than did wild type animals (Fig. 5.5). Tissues from Itchy 
mice were  subsequently subjected to TUNEL to test the hypothesis that higher c-
FLIP levels will protect  germ cells from MEHP-mediated apoptosis (Fig. 5.6). 
Wild type mice underwent typical apoptosis seen previously after 12 hour MEHP 
exposures, with apoptosis confined usually to the furthermost edge of the 
basement membrane. This is characteristic of tubules with damaged Sertoli cells; 
spermatocytes are closer to the basement membrane because Sertoli cell 
cytoplasm is reduced and the lumen has increased. Furthermore, vacuolization is 
evident where germ cells have been lost and the stages have been disorganized. 
 However, TUNEL assays showed higher apoptotic rates in the control 
Itchy mice animal (Fig. 5.6A, panel III) than in the wild type mice treated with 12 
hours of MEHP (Fig. 5.6A, panel II). Cell death levels did not differ significantly 
between Itchy or Itchy plus MEHP, supporting the previous data (Fig. 5.5) that 
mice without  the functional protein were protected from the toxicant. A careful 
count of positive TUNEL-stained cells showed that over half (53%, observation) 
of the apoptotic cells were frozen in metaphase occurring in pachytene 
spermatocytes (Fig. 5.6A, insert). MEHP produced a much smaller number (10%, 
observation) in wild type mice and mostly in less mature leptotene spermatocytes. 
This novel observation implies a link between Itch and the transition between 
metaphase and anaphase during meiosis. Therefore, it is reasonable to see higher 
apoptosis in pachytene germ cells, the site of metaphase during spermatogenesis. 
 Itch deficient tissues expressed a significant level of cyclin B1, a protein 
which associates with cdc2 in the cell cycle (Fig. 5.6B). Cyclins help to activate 
cyclin dependent kinases (cdks) through phosphorylation (Gautier, 1990), (Desai, 
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1992). Cyclin B1 must be degraded prior to the movement of the cell from 
metaphase to anaphase during the cell cycle (Glotzer, 1991). Therefore, increased 
cyclin B1 present in Itchy tissues might be anticipated, given that many of the 
TUNEL labeled cells were frozen in metaphase. The disruption of the cell cycle 
would also resolve the increase in overall apoptosis in the tubules: germ cell loss 
could be explained by fewer passing through cell cycle checkpoints. In such a 
case, augmented c-FLIPL may not protect the cells as apoptosis is mediated by a 
dysfunction in the meiotic process. The above observations, together with the 
morphological data, suggests that Itch is may induce apoptosis through two 
distinct pathways: 1) reduction of c-FLIPL facilitating caspase activation after 
MEHP treatment or 2) meiotic arrest when the protein is totally removed. Thus, 
Itch is probably required for  normal spermatogenesis 
 Removal of Itch in vitro also promotes cell death. In GC-2 cultures treated 
with either 1 µM or 100 nM of Itch siRNA, the Itch protein is knocked-down at 
both 37° C (p53 non-permissive) and 32° C (p53 permissive) temperatures as 
determined by western blot (data not shown). Annexin-PI flow cytometry was 
used to determine the apoptotic response of the GC-2 cells to Itch deficiency (Fig. 
5.7). Cell death quantitation shows increased apoptosis in all samples treated with 
Itch siRNA only or in combination with Jo2. Therefore, Itch is probably required 
for some other, critical function within the germ cell. Keeping with previous 
observations, the apoptosis seen is also greater at 32°C, when p53 is properly 
folded and functional. Therefore, p53 plays a role in sensitizing cells to apoptosis 
when Itch is reduced. 
 The GC-2 line may be of particular use in this investigation because cells 
grown at the permissive temperature have been described to undergo meiosis 
(Hofmann, 1994) (Hofmann, 1995). The heightened apoptosis occurring at the 
permissive temperature after the RNAi of Itch is consistent with a disruption in 
meiosis and support the in vivo data. However, there is controversy as to whether 
GC-2 cells are a suitable modeling this process, as some cellular markers are not 
readily expressed in GC-2 cells (Wolkowicz, 1996). Until further studies are 
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conducted, the meiotic component of Itch in GC-2 cells is speculative. However,  
the data suggests that p53 activity may play a role in promoting apoptosis 
following knock-down in GC-2 cells. One possibly is that p53-transcribed 
proteins such as Fas of Puma aid in clearing cells targeted to undergo apoptosis 
via disruption of the cell cycle. 
 Evidence compiled both in vivo and in vitro support the concept that Itch 
activation can be induced in germ cells following MEHP exposure and that p53 
levels contribute to this process. Itch activation is correlated with c-FLIPL 
reductions, whether directly or through an intermediate protein. In addition, 
experiments in Itchy mice support this finding in that they are partially protected 
from MEHP-mediated germ cell damage. However, complete removal of Itch 
from the testis promotes germ cell apoptosis, possibly through the cell cycle, 
































  Functional spermatogenesis is the cornerstone of male reproductive health. 
Misregulation of this process is detrimental to the ability of the testis to produce 
germ cells and mature sperm, leading to syndromes such as testicular dysgenesis 
and, in extreme cases, infertility. Germ cell numbers are limited by physiological 
conditions and the support of Sertoli cells within the seminiferous tubules. In 
order to maintain an optimal population, a certain number of these cells are 
routinely eliminated by apoptosis during spermatogenesis. However, cell death is 
inappropriately increased by toxicant-induced stress and lead to a variety of 
testicular injuries. Understanding the mechanisms of stress signaling and 
apoptosis in relation to these conditions is therefore of significant physiological 
importance.  
  DEHP is an environmental toxicant, whose major metabolite, MEHP, 
causes testicular injury. MEHP is unusual because it uniquely targets and 
damages the Sertoli cell, a source of nutrients and growth factors for germ cells, 
rather than the germ cell itself. When the paracrine signaling relationship between 
both cells are disrupted, a disturbance in spermatogenesis can occur. Sertoli cell 
injury may impair the spermatogenic process by either removing the structural 
support required for germ cell motility and orientation or by withdrawing factors 
needed for maturation. Death ligands such as FasL or TRAIL are also expressed 
by injured Sertoli cells. In each case, the germ cell is able to detect changes in 
Sertoli support, prompting the engagement of the apoptotic process.  
One of the aims of this dissertation was to evaluate possible mechanisms 
of how germ cells detect stress in response to Sertoli cell injury and through what 
cellular determinants subsequent apoptosis is achieved. The studies revealed 
several novel aspects of germ cell stress signaling, including the observation that 
p53 is a requirement for robust apoptosis in response to MEHP. The 
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transcriptional activity of the p53 protein was shown to be correlative with death 
receptor expression and caspase activation both in vivo and in vitro.  
  The increased activity of p53 is one area of inquiry that could be 
investigated further. Preliminary experiments demonstrated the novel result that 
MEHP can elevate p53 protein levels in vivo. The p53 protein is normally kept at 
a low level by its direct inhibitor, MDM-2 (Momand, 1992). In order to increase 
protein concentrations in the cell, p53 must be stabilized. Commonly, its 
degradation can be forestalled by post-transcriptional phosphorylation on one of 
more of its amino acid residues. These modifications stabilizes p53, either by 
reducing its association with MDM-2 (such as phosphoserine-15 or -20, -18 in 
mouse) or preventing its translocation from the nucleus (phosphoserine-392). 
(Kim, 2004), (Ashcroft, 1999) Our data reflects the latter as a strong possibility, 
given that the -392 residue is phosphorylated in the wild type control and 
increases upon MEHP treatment.  
The significance of more p53 remaining in the nucleus can be witnessed 
by the increases of Fas expressed post-MEHP exposure in vivo. The genes for 
death receptors Fas and DR5 are known to possess p53 response elements. In fact, 
death receptors were shown to be increased upon MEHP treatment in vivo or 
simply by inducing p53 activity in GC-2 cells. The data supports previous studies 
in which MEHP induces the extrinsic pathway upon administration (Lee, 1997), 
(Boekelheide, 1998). A more complete evaluation of  p53 post-transcriptional 
modifications may shed additional light on how MEHP influences the 
transcription factor. Certain amino acid residues, such as threonine-81 and serine-
6, stabilize p53 and are critical for inducing apoptosis (Oleinik, 2007), 
(Buschmann, 2001) 
The role of p53 in testis likely extends beyond stress signaling and into the 
regulation and development of spermatogenesis as well. The expression of p53 is 
important in the activity of UCH-1/3 (ubiquitin c-terminal hydrolase 1 and 3), a 
pair of enzymes  particularly active in the physiological “first wave” of apoptosis  
experienced in the few weeks of spermatogenesis (Kwon, 2005). UCHL enzymes 
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help to maintain a cytosolic pool of ubiquitin. Mice lacking UCHL’s have express 
less active p53 and a reduced ability to initiate apoptosis by targeting cells for 
degradation. The resulting accumulation of damaged or non-functional germ cells 
effectively inhibits levels of normal spermatogenesis (Kwon, 2004). Thus, under 
ordinary conditions p53 could act to rescue testicular tissues from cells that 
interfere with normal sperm production. Other p53-dependent  proteins may fill 
similar functions. For example, another gene under the transcriptional control of 
p53, puma, has also been shown to activate in the physiological pruning of early 
gametes in the first wave (Lizama, 2007). An emerging role for p53 family 
proteins p63 and p73 can has also been seen in spermatogenesis and testicular 
development. In particular, p63 is becoming established another factor in shaping 
germ cell populations in young animals and may be associated with apoptosis 
under some conditions (Petre-Lazar, 2007), (Sayan, 2007). Therefore, an 
investigation into this initial stage of spermatogenesis may elucidate the 
responsibility of p53 to aid in germ cell proliferation in conjunction with its 
apoptotic abilities. 
The preliminary experiments with p53 uncovered an important additional 
finding, reported for the first time, that the TRAIL/DR5 system is able to engage 
apoptosis in germ cells. Additionally, the use of a DR5 agonistic antibody (MD5-
1) effectively increased the overall cell death. The role of these proteins in 
combating tumor cells is of significant interest and has been the subject of many 
chemotherapeutic studies. The reasons explaining TRAIL/DR5-mediated 
apoptosis is often specific for tumorigenic cells is unclear, particularly given its 
wide tissue distribution and expression. The experiments in GC-2 cells designed 
to model the action of MEHP, in which death ligands (TRAIL) are expressed by 
the Sertoli cell after injury and interact with neighboring germ cells. The data 
suggests that DR5 is activated by p53 transcriptional activity and shuttled to the 
membrane, where anti-DR5 antibodies link groups of receptors, possibly 
visualized by confocal microscopy in chapter four. These groups have been 
previously seen in Jo2-augmented Fas “capping” and are often components of 
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lipid rafts (Cremesti, 2001), (Grassme, 2001). Whether or not DR5 is truly 
experiencing capping is not certain, though the data supports that p53 status and 
death receptor expression is up-regulated in response to stress signaling. 
 Perhaps more importantly is the recognition that stress can institute a 
TRAIL/DR5 program of cell death in normal physiological cells. Extensive 
research has been dedicated to the coupling of TRAIL with agonistic antibodies in 
an effort to halt tumor progression (Uno, 2006), (Takeda, 2004), (Ichikawa, 
2001). A little explored side effect is the inappropriate prompting of apoptosis in 
certain highly proliferative cell populations that are not cancerous. Thus, in 
tissues such as the testis, engagement of the TRAIL/DR5 system may induce cell 
death in normal cells in addition to those that are cancerous. A supplementary 
study in other proliferative tissues expressing TRAIL may yield similar results 
and could potentially restrict the safe use of chemotherapeutic mixtures.  
 The impediment of apoptosis through the extrinsic pathway is often 
through the caspase-8 inhibitor c-FLIP. The ability of the protein to saturate 
procaspase-8 binding sites at the DISC and inhibit its activation is well 
established and seen in many diverse cell types. However, its regulation has been 
in large part limited to the knowledge that it is a fast turn-over protein likely 
controlled through ubiquitinylation. We report here that c-FLIPL is reduced in 
response to MEHP in mouse spermatocytes and is ubiquitinylated in the 
spermatocyte-like germ cell line GC-2. Furthermore, the degradation is linked to 
the activity of p53. From chapters three and four, it was shown that stress applied 
to either mice or cultured cells will induce p53-dependent death receptor 
expression, which in turn shifts the homeostatic balance of germ cells to 
apoptosis.  
We sought to further understand how c-FLIPL could be degraded by 
determining if certain ubiquitin E3 ligase would initiate this process. The E3 
ligase specific for its degradation is not known. Itch was chosen as a candidate 
due to its involvement in the TNF-alpha -mediated ubiquitinylation of c-FLIPL in 
liver cells, the first study to directly implicate a specific E3 ligase in its 
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degradation. TNF-alpha is a ligand that reacts with its receptor, TNFR, and is 
similar in action to the Fas /FasL system promoted following MEHP treatments. 
Hepatocytes are also a cell type that undergoes TRAIL-mediated apoptosis under 
physiological conditions. Only one study had investigated Itch in the testis and the 
focus of their investigation was in the Sertoli cell tight junctions and not in germ 
cells (Lui, 2005).  
Itch activity is increased in response MEHP and appears to play a vital 
role in testicular apoptosis (chapter five). However, its direct role in 
ubiquitinylating c-FLIP remains to be validated, and other E3 ligases may 
regulate the protein. One possibility that has been advanced is TRAF2 (TNF-R 
associated factor 2), which associates and decreases c-FLIPL in response to 
TRAIL-mediated  apoptosis in tumor cells (Zhang, 2004) TRAF2 also migrates to 
lipid rafts, where Fas and DR5 signals are often elevated amplified, and may aid 
in c-FLIP ubquitinylation after T-cell activation (Misra, 2007). However, the 
traditional extrinsic pathway may not be employed, as there some evidence that 
death receptors are expendable in this reaction. TRAF2 and its association with 
threonine/serine kinase RIP and has been implicated in the activation of caspase-8 
and cell cycle arrest (Jin, 2006). A new E3 ligase, MEX (MEKK1-associating), 
may show promise as a regulator of c-FLIP due to its co-expression with Fas and 
DR5, and activation of caspase-8 (Nishito, 2006). In addition, MEX is 
predominately expressed in the testis. 
 Itchy mice showed higher levels of c-FLIPL and partial protection from 
MEHP. However, an intriguing observation in these animals is that removal of 
Itch expression actually promotes death in germ cells as well, independently of 
MEHP (unpublished observations). Caspase-8 activation is high in untreated 
Itchy, which correlates with high basal apoptosis levels. Furthermore, the 
microscopic examination reveals that most of the apoptotic cells are frozen in 
metaphase and immunoblotting of shows that cyclin B1 degradation is impaired 
when Itch is not functional. Thus, Itch may play a previously undescribed role in 
the cell cycle progression. A knockdown of Itch in GC-2 cells also promoted cell 
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death. Interestingly, p53 expression was important in apoptotic levels. Since p53 
is a regulator of the cell cycle in addition to apoptotic signaling, its influence 
would justify a potential investigation into this area. 
 Taken together, the observations open a new and thus far unstudied aspect 
of Itch in the testis. Spermatocytes are the site of meiosis in spermatogenesis and 
also the germ cell subtype most reliant on the proper function of the Sertoli cell. 
That pachytene spermatocytes are targeted for apoptosis is logical, since they are 
the site of recombination and take the longest to transition during the cell cycle. 
Therefore, these cells are likely the most sensitive not only to changes in Sertoli 
cell signaling/apoptosis but also alterations in proteins that regulate the process of 
meiosis itself. There is little information on testis specific E3 ligases and their 
interaction with germ cell meiotic proteins.  
The influence of MEHP on the meiotic  process would be a fertile field of 
investigation and further uncover details on why germ cell numbers are reduced 
under stress conditions. The anaphase promoting complex (APC) has been 
established as the source of ubiquitinylation and degradation of cyclin B1 
(Glotzer, 1991). Interestingly, the APC also uses an E3 ligase to induce 
degradation. The data compiled here suggests that the Itch E3 ligase may be used 
for ubiquitinylation of substrates during this stage of the cell cycle as well. Other 
ligases have been discovered in meiosis and spermatogenesis, such as shia1, 
which may control aspects of chromosome segregation, and promote a metaphase 
block (Dickins, 2002). Like Itch, Shia1 deficient mice are fertile but are but 
display difficulty transitioning through the meiotic phases, possibly resulting in 
meiotic arrest.  
Perhaps Itch acts to regulate one or more of the  proteins involved with the 
orderly progression of the cell cycle during spermatocyte progression. There is 
enormous redundancy in cells; Itch may act to aid APF under cellular stress or 
another physiological condition. This function could prove to be an interesting 
continuation of the work done in spermatocytes, which are often the most 
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sensitive germ cell to apoptosis, not only after MEHP, but a wide range of 
toxicants. 
 The studies to this point have suggested p53 as critical first response to 
germ cell stress. Our data has firmly established a link between the ability of 
MEHP to promote apoptosis and activate p53. The hypothesis that p53 is a 
sensitizer of germ cell stress has been supported in GC-2 cells and with p53 
deficient mice, which express fewer death receptors, reduced caspase-8 activity, 
and lower incidence of apoptosis. The transcriptional targets of p53, death 
receptors, likely drive apoptosis and effect c-FLIPL degradation. The literature 
shows that death receptors can promote JNK1 activity by stimulating  upstream 
kinases: MKK4 and MKK7 can be induced by Fas and TNF-alpha respectively 
(Toyoshima, 1997), (Moriguchi, 1997). Hence, our experiments suggest that 
upstream signaling factors that activate JNK1 activation may be triggered by 
MEHP treatments.  
However, an important note is that p53 can be stabilized by MAP kinases. 
MAP kinases are serine/threonine kinases that have been linked to many different 
cellular processes including the regulation of cell cycle progression, proliferation, 
differentiation, and cell death (Bogoyevitch, 2006). The mechanism bears 
examination, particularly since p53 is a phosphorylation target JNK1, which also 
activates Itch. A further line of research would be to identify if a particular MAP 
kinases influences the stability of p53 in addition to activating Itch. For example, 
future experiments could use JNK knock-out mice to determine if any protection 
is observed in the testis. In addition, knowing which upstream activators of JNK1 
could produce clues as to the external stimuli that are ultimately responsible for 
initiating the MAPK kinase cascade in germ cells following MEHP-induced 
Sertoli cell injury.  
 Our studies have made important advancements in identifying proteins 
intimately involved with the MEHP-mediated toxicity of germ cells. Our initial 
hypothesis that p53 participates as a monitor of cell stress apoptosis has been 
supported experimentally both in rodent in vivo models and in culture. Of 
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particular note is that spermatocytes, often considered to be the most sensitive 
population to stress induced apoptosis, are also readily killed by the TRAIL/DR5 
system and that p53 in part mediates this reaction. Our work has also uncovered 
the potential importance of Itch in germ cell homeostasis. While the original idea 
that Itch mediates c-FLIPL degradation received some support, additional 
experiments will have to be completed to convincingly establish this. However, 
the possible role of Itch in meiotic progression is a novel observation that may 
explain why spermatocytes specifically undergo apoptosis in knockout mice. The 
conclusions of the research have been summarized in the germ cell stress model 
(Fig. 6.1A/B). 
 The ultimate purpose of this research is to explain the mechanism of 
MEHP in male infertility. The supportive capacity of the Sertoli cell is known to 
be reduced when damaged by MEHP. MEHP is thought to induce derangements 
in the seminiferous tubules collectively known as testicular dysgenesis syndrome, 
a possible precursor to male infertility. Our study had addressed the downstream 
effects of this injury and its impact on the most prominent cell in the adluminal 
compartment, the spermatocyte. The homeostasis of these cells plays a key part in 
the on-going ability of the testis to produce mature sperm and their mechanism of 
apoptosis is integral to understanding how spermatogenesis is regulated in 



































Fig. 6.1A Summary Figure. Testicular treatments of MEHP cause Sertoli cell 
damage and ensuing apoptosis in the germ cell. The p53 protein is stabilized in 
response to cellular stress and translocates to the nucleus where death receptor 
transcription is increased. Death receptors are trafficked the membrane, where 



























Fig. 6.1B Summary Figure. Triggering of death receptor/ligand complexes 
promote DISC formation and apoptosis through the extrinsic pathway. Apoptosis 
can be blocked by c-FLIPL. The E3 ligase Itch can potentially promote apoptosis 
through ubiquitinylating FLIPL. However, removal of Itch also induces cell death, 
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